The	O
evolutionarily	B-DNA
conserved	I-DNA
sequence	I-DNA
upstream	O
of	O
the	O
human	B-protein
Ig	I-protein
heavy	I-protein
chain	I-protein
S	I-protein
gamma	I-protein
3	I-protein
region	I-protein
is	O
an	O
inducible	B-DNA
promoter	I-DNA
:	O
synergistic	O
activation	O
by	O
CD40	B-protein
ligand	I-protein
and	O
IL-4	B-protein
via	O
cooperative	O
NF-kappa	B-DNA
B	I-DNA
and	I-DNA
STAT-6	I-DNA
binding	I-DNA
sites	I-DNA
.	O

Germline	O
C	O
gamma	O
gene	O
transcription	O
is	O
a	O
crucial	O
event	O
in	O
the	O
process	O
that	O
leads	O
to	O
switch	O
DNA	O
recombination	O
to	O
IgG	B-protein
,	O
but	O
its	O
regulation	O
in	O
the	O
human	O
is	O
poorly	O
understood	O
.	O

We	O
took	O
advantage	O
of	O
our	O
monoclonal	O
model	O
of	O
germinal	B-cell_type
center	I-cell_type
B	I-cell_type
cell	I-cell_type
differentiation	O
,	O
IgM+	B-cell_line
IgD+	I-cell_line
CL-01	I-cell_line
cells	I-cell_line
,	O
to	O
define	O
the	O
role	O
of	O
the	O
I	B-protein
gamma	I-protein
3	I-protein
evolutionarily	B-DNA
conserved	I-DNA
sequence	I-DNA
(	O
ECS	B-DNA
)	O
in	O
the	O
germline	B-DNA
transcriptional	O
activation	O
of	O
the	O
human	B-DNA
C	I-DNA
gamma	I-DNA
3	I-DNA
gene	I-DNA
.	O

The	O
I	B-protein
gamma	I-protein
3	I-protein
ECS	B-DNA
lies	O
upstream	O
of	O
the	O
major	B-DNA
I	I-DNA
gamma	I-DNA
3	I-DNA
transcription	I-DNA
initiation	I-DNA
site	I-DNA
and	O
displays	O
more	O
than	O
90	O
%	O
identity	O
with	O
the	O
corresponding	O
human	B-DNA
I	I-DNA
gamma	I-DNA
1	I-DNA
,	O
I	B-DNA
gamma	I-DNA
2	I-DNA
,	O
and	O
I	B-DNA
gamma	I-DNA
4	I-DNA
regions	O
.	O

Reporter	B-DNA
luciferase	I-DNA
gene	I-DNA
vectors	I-DNA
containing	O
the	O
human	B-DNA
gamma	I-DNA
3	I-DNA
ECS	I-DNA
were	O
used	O
to	O
transfect	O
CL-01	B-cell_line
cells	I-cell_line
,	O
which	O
have	O
been	O
shown	O
to	O
undergo	O
Smu	O
--	O
>	O
S	O
gamma	O
3	O
DNA	O
recombination	O
,	O
upon	O
engagement	O
of	O
CD40	B-protein
by	O
CD40	B-protein
ligand	I-protein
(	O
CD40L	B-protein
)	O
and	O
exposure	O
to	O
IL-4	B-protein
.	O

In	O
these	O
transfected	O
CL-01	B-cell_line
cells	I-cell_line
,	O
CD40	O
:	O
CD40L	B-protein
engagement	O
and	O
exposure	O
to	O
IL-4	B-protein
synergistically	O
induced	O
gamma	O
3	O
ECS-dependent	O
luciferase	B-DNA
reporter	I-DNA
gene	I-DNA
activation	O
.	O

Targeted	O
mutational	O
analysis	O
demonstrated	O
that	O
a	O
tandem	O
NF-kappa	B-DNA
B/Rel	I-DNA
binding	I-DNA
motif	I-DNA
is	O
critical	O
for	O
the	O
gamma	B-DNA
3	I-DNA
ECS	I-DNA
responsiveness	O
to	O
both	O
CD40L	B-protein
and	O
IL-4	B-protein
,	O
while	O
a	O
STAT-6-binding	B-DNA
site	I-DNA
is	O
additionally	O
required	O
for	O
IL-4	B-protein
inducibility	O
.	O

Electrophoretic	O
mobility	O
shift	O
assays	O
showed	O
that	O
p50/p65/c-Rel	B-protein
and	O
STAT-6	B-protein
are	O
effectively	O
induced	O
by	O
CD40L	B-protein
and	O
IL-4	B-protein
,	O
respectively	O
,	O
and	O
bind	O
to	O
specific	O
DNA	B-DNA
motifs	I-DNA
within	O
the	O
ECS	B-DNA
.	O

These	O
partially	O
overlapping	O
CD40L	B-DNA
and	I-DNA
IL-4	I-DNA
responsive	I-DNA
elements	I-DNA
are	O
functionally	O
cooperative	O
as	O
the	O
disruption	O
of	O
one	O
of	O
them	O
prevents	O
synergistic	O
promoter	O
activation	O
.	O

Thus	O
,	O
the	O
gamma	B-DNA
3	I-DNA
ECS	I-DNA
is	O
an	O
inducible	O
promoter	O
containing	O
cis	B-DNA
elements	I-DNA
that	O
critically	O
mediate	O
CD40L	B-protein
and	O
IL-4	B-protein
-triggered	O
transcriptional	O
activation	O
of	O
the	O
human	B-DNA
C	I-DNA
gamma	I-DNA
3	I-DNA
gene	I-DNA
.	O

Le	NULL
~	NULL
.	NULL

__	NULL
The	NULL
Attune	NULL
``	NULL
NXT	NULL
Flow	NULL
Cytometer	NULL
system	NULL
_-	NULL
_-	NULL
Let	NULL
's	NULL
get	NULL
to	NULL
the	NULL
science	NULL
invitrogen	NULL
The	NULL
Evolutionarily	NULL
Conserved	NULL
Sequence	NULL
Pn	NULL
1	NULL
,	NULL
Aﬁxlﬁiijllgﬁzélo	NULL
gy	NULL
Upstream	NULL
of	NULL
the	NULL
Human	NULL
Ig	NULL
Heavy	NULL
Chain	NULL
S	NULL
y3	NULL
Region	NULL
Is	NULL
an	NULL
Inducible	NULL
Promoter	NULL
:	NULL
Synergistic	NULL
20	NULL
,	NULL
2	NULL
,	NULL
Activation	NULL
by	NULL
CD40	NULL
Ligand	NULL
and	NULL
IL-4	NULL
Via	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
_	NULL
(	NULL
Copperative	NULL
NF-	NULL
xB	NULL
and	NULL
STAT-6	NULL
Binding	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Sites	NULL
Andras	NULL
Schaffer	NULL
,	NULL
Andrea	NULL
Cerutti	NULL
,	NULL
Shefali	NULL
Shah	NULL
,	NULL
Hong	NULL
Zan	NULL
and	NULL
Paolo	NULL
Casali	NULL
J	NULL
Immunol	NULL
1999	NULL
;	NULL
162:5327-5336	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/9/5327	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
48	NULL
articles	NULL
,	NULL
33	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/9/5327	NULL
.	NULL

full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Evolutionarily	NULL
Conserved	NULL
Sequence	NULL
Upstream	NULL
of	NULL
the	NULL
Human	NULL
Ig	NULL
Heavy	NULL
Chain	NULL
Sy3	NULL
Region	NULL
Is	NULL
an	NULL
Inducible	NULL
Promoter	NULL
:	NULL
Synergistic	NULL
Activation	NULL
by	NULL
CD40	NULL
Ligand	NULL
and	NULL
IL-4	NULL
Via	NULL
Cooperative	NULL
NF-B	NULL
and	NULL
STAT-6	NULL
Binding	NULL
Sites	NULL
'	NULL
Andras	NULL
Schaffer	NULL
,	NULL
*	NULL
``	NULL
Andrea	NULL
Cerutti	NULL
,	NULL
*	NULL
Shefali	NULL
Shabh	NULL
,	NULL
*	NULL
Hong	NULL
Zan	NULL
,	NULL
*	NULL
and	NULL
Paolo	NULL
Casali®*	NULL
'	NULL
Germline	NULL
Cy	NULL
gene	NULL
transcription	NULL
is	NULL
a	NULL
crucial	NULL
event	NULL
in	NULL
the	NULL
process	NULL
that	NULL
leads	NULL
to	NULL
switch	NULL
DNA	NULL
recombination	NULL
to	NULL
IgG	NULL
,	NULL
but	NULL
its	NULL
regulation	NULL
in	NULL
the	NULL
human	NULL
is	NULL
poorly	NULL
understood	NULL
.	NULL

We	NULL
took	NULL
advantage	NULL
of	NULL
our	NULL
monoclonal	NULL
model	NULL
of	NULL
germinal	NULL
center	NULL
B	NULL
cell	NULL
differentiation	NULL
,	NULL
IgM	NULL
*	NULL
IgD*	NULL
CL-01	NULL
cells	NULL
,	NULL
to	NULL
define	NULL
the	NULL
role	NULL
of	NULL
the	NULL
ILy3	NULL
evolutionarily	NULL
conserved	NULL
sequence	NULL
(	NULL
ECS	NULL
)	NULL
in	NULL
the	NULL
germline	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
human	NULL
Cy3	NULL
gene	NULL
.	NULL

The	NULL
1y3	NULL
ECS	NULL
lies	NULL
upstream	NULL
of	NULL
the	NULL
major	NULL
I1y3	NULL
transcription	NULL
initiation	NULL
site	NULL
and	NULL
displays	NULL
more	NULL
than	NULL
90	NULL
%	NULL
identity	NULL
with	NULL
the	NULL
corresponding	NULL
human	NULL
Iy1	NULL
,	NULL
Iy2	NULL
,	NULL
and	NULL
Iy4	NULL
regions	NULL
.	NULL

Reporter	NULL
luciferase	NULL
gene	NULL
vectors	NULL
containing	NULL
the	NULL
human	NULL
y3	NULL
ECS	NULL
were	NULL
used	NULL
to	NULL
transfect	NULL
CL-01	NULL
cells	NULL
,	NULL
which	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
undergo	NULL
Sm-	NULL
>	NULL
Sy3	NULL
DNA	NULL
recombination	NULL
,	NULL
upon	NULL
engagement	NULL
of	NULL
CD40	NULL
by	NULL
CD40	NULL
ligand	NULL
(	NULL
CD4O0L	NULL
)	NULL
and	NULL
exposure	NULL
to	NULL
IL-4	NULL
.	NULL

In	NULL
these	NULL
transfected	NULL
CL-01	NULL
cells	NULL
,	NULL
€CD40	NULL
:	NULL
CD40L	NULL
engagement	NULL
and	NULL
exposure	NULL
to	NULL
IL-4	NULL
synergistically	NULL
induced	NULL
y3	NULL
ECS-dependent	NULL
luciferase	NULL
reporter	NULL
gene	NULL
activation	NULL
.	NULL

Targeted	NULL
mutational	NULL
analysis	NULL
demonstrated	NULL
that	NULL
a	NULL
tandem	NULL
NF-xB/Re	NULL
!	NULL

l	NULL
binding	NULL
motif	NULL
is	NULL
critical	NULL
for	NULL
the	NULL
y3	NULL
ECS	NULL
responsiveness	NULL
to	NULL
both	NULL
CD40L	NULL
and	NULL
IL-4	NULL
,	NULL
while	NULL
a	NULL
STAT-6-binding	NULL
site	NULL
is	NULL
additionally	NULL
required	NULL
for	NULL
IL-4	NULL
inducibility	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
showed	NULL
that	NULL
p50/p65/c-Rel	NULL
and	NULL
STAT-6	NULL
are	NULL
effectively	NULL
induced	NULL
by	NULL
CD4O0L	NULL
and	NULL
IL-4	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
bind	NULL
to	NULL
specific	NULL
DNA	NULL
motifs	NULL
within	NULL
the	NULL
ECS	NULL
.	NULL

These	NULL
partially	NULL
overlapping	NULL
CD40L	NULL
and	NULL
IL-4	NULL
responsive	NULL
elements	NULL
are	NULL
functionally	NULL
cooperative	NULL
as	NULL
the	NULL
disruption	NULL
of	NULL
one	NULL
of	NULL
them	NULL
prevents	NULL
synergistic	NULL
promoter	NULL
activation	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
y3	NULL
ECS	NULL
is	NULL
an	NULL
inducible	NULL
promoter	NULL
containing	NULL
cis	NULL
elements	NULL
that	NULL
critically	NULL
mediate	NULL
CD4O0L	NULL
and	NULL
IL-4-triggered	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
human	NULL
Cy3	NULL
gene	NULL
.	NULL

lass	NULL
switching	NULL
modulates	NULL
the	NULL
biological	NULL
effector	NULL
functions	NULL
of	NULL
Igs	NULL
and	NULL
contributes	NULL
to	NULL
the	NULL
maturation	NULL
of	NULL
the	NULL
Ab	NULL
re	NULL
sponse	NULL
(	NULL
reviewed	NULL
in	NULL
Refs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

The	NULL
substitution	NULL
of	NULL
the	NULL
Ig	NULL
heavy	NULL
chain	NULL
constant	NULL
region	NULL
in	NULL
the	NULL
primary	NULL
response	NULL
with	NULL
a	NULL
Cy	NULL
,	NULL
Ca	NULL
,	NULL
or	NULL
Ce	NULL
region	NULL
in	NULL
the	NULL
secondary	NULL
response	NULL
is	NULL
critical	NULL
for	NULL
the	NULL
efficient	NULL
clearance	NULL
of	NULL
Ag	NULL
by	NULL
conferring	NULL
to	NULL
Abs	NULL
the	NULL
ability	NULL
to	NULL
enter	NULL
the	NULL
extravascular	NULL
space	NULL
,	NULL
being	NULL
secreted	NULL
across	NULL
digestive	NULL
or	NULL
respiratory	NULL
surfaces	NULL
,	NULL
and	NULL
interact	NULL
with	NULL
phagocytic	NULL
,	NULL
histamine-releasing	NULL
,	NULL
and	NULL
cytotoxic	NULL
effector	NULL
cells	NULL
.	NULL

Ig	NULL
class	NULL
switching	NULL
is	NULL
effected	NULL
by	NULL
deletional	NULL
DNA	NULL
recombination	NULL
between	NULL
switch	NULL
(	NULL
S	NULL
)	NULL
``	NULL
regions	NULL
located	NULL
5	NULL
'	NULL
of	NULL
each	NULL
C	NULL
;	NULL
,	NULL
gene	NULL
(	NULL
3-6	NULL
)	NULL
.	NULL

Switching	NULL
to	NULL
a	NULL
given	NULL
downstream	NULL
CJ	NULL
gene	NULL
is	NULL
preceded	NULL
by	NULL
transcription	NULL
of	NULL
the	NULL
targeted	NULL
gene	NULL
in	NULL
the	NULL
form	NULL
of	NULL
an	NULL
intermediate	NULL
RNA	NULL
encompassing	NULL
a	NULL
noncoding	NULL
exon	NULL
,	NULL
called	NULL
*Division	NULL
of	NULL
Molecular	NULL
Immunology	NULL
,	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
Weill	NULL
Medical	NULL
College	NULL
of	NULL
Cornell	NULL
University	NULL
,	NULL
and	NULL
*The	NULL
Immunology	NULL
Program	NULL
,	NULL
Weill	NULL
Graduate	NULL
School	NULL
of	NULL
Medical	NULL
Sciences	NULL
of	NULL
Cornell	NULL
University	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
10021	NULL
Received	NULL
for	NULL
publication	NULL
September	NULL
15	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
February	NULL
3	NULL
,	NULL
1999	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
U.S.	NULL
Public	NULL
Health	NULL
Service	NULL
Grant	NULL
AR	NULL
40908	NULL
(	NULL
to	NULL
P.C	NULL
.	NULL
)	NULL

A.S.	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
predoctoral	NULL
fellowship	NULL
from	NULL
the	NULL
Cancer	NULL
Research	NULL
Institute	NULL
(	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
)	NULL
and	NULL
by	NULL
a	NULL
Summer	NULL
Student	NULL
Fellowship	NULL
from	NULL
the	NULL
Arthritis	NULL
Foundation	NULL
(	NULL
New	NULL
York	NULL
Chapter	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

2	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Paolo	NULL
Casali	NULL
,	NULL
Weill	NULL
Medical	NULL
College	NULL
of	NULL
Cornell	NULL
University	NULL
,	NULL
1300	NULL
York	NULL
Avenue	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
10021	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
pcasali	NULL
@	NULL
mail.med.cornell.edu	NULL
3	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
S	NULL
,	NULL
switch	NULL
(	NULL
region	NULL
)	NULL
;	NULL
I	NULL
,	NULL
intervening	NULL
(	NULL
region	NULL
)	NULL
;	NULL
y-Cy	NULL
,	NULL
germline	NULL
Ig	NULL
transcript	NULL
;	NULL
CD40L	NULL
,	NULL
CD40	NULL
ligand	NULL
;	NULL
RE	NULL
,	NULL
responsive	NULL
element	NULL
;	NULL
ECS	NULL
,	NULL
evolutionarily	NULL
conserved	NULL
sequence	NULL
;	NULL
V	NULL
,	NULL
,	NULL
DJ	NULL
,	NULL
-C	NULL
;	NULL
,	NULL
,	NULL
productive	NULL
Ig	NULL
transcript	NULL
;	NULL
C/EBP	NULL
,	NULL
CCAAT/	NULL
enhancer-binding	NULL
protein	NULL
;	NULL
BSAP	NULL
,	NULL
B	NULL
cell	NULL
lineage-specific	NULL
activator	NULL
protein	NULL
;	NULL
GAS	NULL
,	NULL
IFN-y	NULL
activation	NULL
site	NULL
;	NULL
wt	NULL
,	NULL
wild	NULL
type	NULL
;	NULL
ISRE	NULL
,	NULL
IFN-stimulated	NULL
responsive	NULL
element	NULL
;	NULL
BCR	NULL
,	NULL
B	NULL
cell	NULL
receptor	NULL
.	NULL

Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1999	NULL
,	NULL
162	NULL
;	NULL
5327-5336.	NULL
intervening	NULL
(	NULL
I	NULL
)	NULL
region	NULL
,	NULL
the	NULL
S	NULL
region	NULL
,	NULL
and	NULL
the	NULL
C	NULL
;	NULL
,	NULL
gene	NULL
itself	NULL
(	NULL
7-11	NULL
)	NULL
.	NULL

Splicing	NULL
of	NULL
the	NULL
intermediate	NULL
I	NULL
;	NULL
,	NULL
-S	NULL
;	NULL
,	NULL
-C	NULL
,	NULL
,	NULL
RNA	NULL
juxtaposes	NULL
the	NULL
I	NULL
,	NULL
,	NULL
with	NULL
the	NULL
C	NULL
;	NULL
;	NULL
exon	NULL
and	NULL
leads	NULL
to	NULL
the	NULL
formation	NULL
of	NULL
I	NULL
;	NULL
;	NULL
-C	NULL
;	NULL
RNA	NULL
(	NULL
germline	NULL
transcript	NULL
)	NULL
,	NULL
which	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
S	NULL
DNA	NULL
recombination	NULL
by	NULL
increasing	NULL
the	NULL
recombinogenic	NULL
activity	NULL
of	NULL
the	NULL
S	NULL
region	NULL
and/or	NULL
its	NULL
accessibility	NULL
to	NULL
the	NULL
S	NULL
recombinase	NULL
machinery	NULL
(	NULL
12	NULL
)	NULL
.	NULL

CD40	NULL
engagement	NULL
by	NULL
CD40	NULL
ligand	NULL
(	NULL
CD4O0L	NULL
,	NULL
CD154	NULL
)	NULL
critically	NULL
triggers	NULL
Ig	NULL
class	NULL
switching	NULL
(	NULL
13-15	NULL
)	NULL
.	NULL

Patients	NULL
lacking	NULL
an	NULL
intact	NULL
CD40L	NULL
gene	NULL
display	NULL
elevated	NULL
serum	NULL
IgM	NULL
and	NULL
no	NULL
secondary	NULL
IgG	NULL
,	NULL
IgA	NULL
,	NULL
and	NULL
IgE	NULL
isotypes	NULL
(	NULL
hyperIgM	NULL
syndrome	NULL
)	NULL
(	NULL
16	NULL
)	NULL
.	NULL

As	NULL
we	NULL
have	NULL
shown	NULL
,	NULL
upon	NULL
CD40	NULL
engagement	NULL
by	NULL
CD4O0L	NULL
,	NULL
human	NULL
B	NULL
cells	NULL
express	NULL
germline	NULL
Iy-Cy	NULL
,	NULL
and	NULL
transcripts	NULL
,	NULL
and	NULL
eventually	NULL
undergo	NULL
Su-	NULL
Su-Sal	NULL
,	NULL
and	NULL
Su-	NULL
DNA	NULL
recombination	NULL
,	NULL
which	NULL
is	NULL
mediated	NULL
by	NULL
(	NULL
endogenous	NULL
)	NULL
TGF-B	NULL
secreted	NULL
by	NULL
the	NULL
CD4O-induced	NULL
B	NULL
cells	NULL
(	NULL
13-15	NULL
)	NULL
.	NULL

As	NULL
we	NULL
have	NULL
also	NULL
shown	NULL
,	NULL
switch	NULL
DNA	NULL
recombination	NULL
to	NULL
§y3	NULL
,	NULL
Sy2	NULL
,	NULL
Sy4	NULL
,	NULL
or	NULL
Se	NULL
requires	NULL
IL-4	NULL
,	NULL
possibly	NULL
due	NULL
to	NULL
its	NULL
synergistic	NULL
effect	NULL
on	NULL
the	NULL
CD4O-induced	NULL
transcription	NULL
of	NULL
the	NULL
corresponding	NULL
germline	NULL
genes	NULL
(	NULL
13-15	NULL
)	NULL
.	NULL

Studies	NULL
in	NULL
murine	NULL
B	NULL
cell	NULL
lines	NULL
have	NULL
suggested	NULL
that	NULL
the	NULL
germline	NULL
transcription	NULL
of	NULL
the	NULL
Cy1	NULL
and	NULL
the	NULL
Ce	NULL
genes	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
and	NULL
STAT-6	NULL
,	NULL
which	NULL
bind	NULL
to	NULL
highly	NULL
conserved	NULL
cis	NULL
promoter	NULL
elements	NULL
located	NULL
upstream	NULL
of	NULL
the	NULL
Iyl	NULL
and	NULL
Ie	NULL
regions	NULL
(	NULL
17-20	NULL
)	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
Ig	NULL
class	NULL
switching	NULL
has	NULL
been	NULL
further	NULL
suggested	NULL
by	NULL
findings	NULL
showing	NULL
the	NULL
reduced	NULL
ability	NULL
of	NULL
B	NULL
cells	NULL
from	NULL
mice	NULL
genetically	NULL
deficient	NULL
in	NULL
p50	NULL
,	NULL
c-Rel	NULL
,	NULL
or	NULL
STAT-6	NULL
protein	NULL
to	NULL
switch	NULL
to	NULL
IgG1	NULL
,	NULL
or	NULL
IgE	NULL
,	NULL
upon	NULL
appropriate	NULL
stimulation	NULL
in	NULL
vivo	NULL
or	NULL
in	NULL
vitro	NULL
(	NULL
21-24	NULL
)	NULL
.	NULL

Reporter	NULL
assays	NULL
utilizing	NULL
human	NULL
DG75	NULL
,	NULL
DND39	NULL
,	NULL
Raji	NULL
,	NULL
and	NULL
SDL-M1	NULL
cell	NULL
lines	NULL
have	NULL
led	NULL
to	NULL
the	NULL
identification	NULL
of	NULL
the	NULL
human	NULL
germline	NULL
Ce	NULL
,	NULL
Cal	NULL
,	NULL
and	NULL
Ca2	NULL
gene	NULL
promoters	NULL
and	NULL
to	NULL
the	NULL
delineation	NULL
of	NULL
their	NULL
respective	NULL
IL-4	NULL
or	NULL
TGF-	NULL
responsive	NULL
elements	NULL
(	NULL
REs	NULL
)	NULL
(	NULL
25-31	NULL
)	NULL
.	NULL

However	NULL
,	NULL
distinct	NULL
CD40	NULL
REs	NULL
within	NULL
these	NULL
promoters	NULL
have	NULL
not	NULL
0022-1767/99/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
5328	NULL
been	NULL
defined	NULL
,	NULL
and	NULL
their	NULL
corresponding	NULL
CD4O0-induced	NULL
frans-factors	NULL
have	NULL
not	NULL
been	NULL
identified	NULL
.	NULL

The	NULL
utilization	NULL
of	NULL
SSK41	NULL
cells	NULL
has	NULL
allowed	NULL
the	NULL
identification	NULL
of	NULL
a	NULL
PMA-	NULL
and	NULL
IL-4-inducible	NULL
DNA	NULL
fragment	NULL
upstream	NULL
of	NULL
the	NULL
major	NULL
human	NULL
I1y3-Cy3	NULL
transcriptional	NULL
initiation	NULL
site	NULL
,	NULL
but	NULL
PMA	NULL
is	NULL
not	NULL
a	NULL
switch-inducing	NULL
stimulus	NULL
,	NULL
and	NULL
PMA	NULL
and	NULL
IL-4	NULL
REs	NULL
were	NULL
not	NULL
defined	NULL
within	NULL
the	NULL
tested	NULL
DNA	NULL
region	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
since	NULL
none	NULL
of	NULL
the	NULL
above	NULL
human	NULL
cell	NULL
lines	NULL
can	NULL
be	NULL
induced	NULL
to	NULL
undergo	NULL
switch	NULL
DNA	NULL
recombination	NULL
,	NULL
the	NULL
above	NULL
studies	NULL
could	NULL
not	NULL
address	NULL
the	NULL
correlation	NULL
between	NULL
the	NULL
transcriptional	NULL
potential	NULL
of	NULL
the	NULL
tested	NULL
C	NULL
,	NULL
,	NULL
gene	NULL
promoters	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
switch	NULL
DNA	NULL
recombination	NULL
,	NULL
thereby	NULL
failing	NULL
to	NULL
provide	NULL
information	NULL
on	NULL
the	NULL
CD40	NULL
and	NULL
cytokine-dependent	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
Cy	NULL
genes	NULL
.	NULL

The	NULL
identification	NULL
of	NULL
germline	NULL
Cy	NULL
gene	NULL
promoters	NULL
would	NULL
require	NULL
the	NULL
availability	NULL
of	NULL
a	NULL
B	NULL
cell	NULL
line	NULL
that	NULL
is	NULL
readily	NULL
trans-fectable	NULL
and	NULL
that	NULL
can	NULL
undergo	NULL
IgG	NULL
switching	NULL
in	NULL
response	NULL
to	NULL
physiological	NULL
stimuli	NULL
,	NULL
that	NULL
is	NULL
,	NULL
CD4OL	NULL
:	NULL
CDA4O	NULL
engagement	NULL
and	NULL
exposure	NULL
to	NULL
appropriate	NULL
cytokines	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
sequences	NULL
lying	NULL
upstream	NULL
of	NULL
Sy	NULL
regions	NULL
show	NULL
a	NULL
high	NULL
degree	NULL
of	NULL
conservation	NULL
among	NULL
all	NULL
four	NULL
human	NULL
Cy	NULL
isotypes	NULL
and	NULL
are	NULL
highly	NULL
homologous	NULL
(	NULL
65	NULL
%	NULL
)	NULL
within	NULL
a	NULL
175-bp	NULL
region	NULL
to	NULL
the	NULL
corresponding	NULL
sequence	NULL
of	NULL
the	NULL
mouse	NULL
Cy	NULL
promoters	NULL
(	NULL
evolutionarily	NULL
conserved	NULL
sequence	NULL
,	NULL
ECS	NULL
)	NULL
(	NULL
6	NULL
,	NULL
9	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
these	NULL
observations	NULL
,	NULL
the	NULL
human	NULL
ECS-Iy	NULL
regions	NULL
have	NULL
been	NULL
hypothesized	NULL
to	NULL
regulate	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
corresponding	NULL
germline	NULL
Cy	NULL
genes	NULL
(	NULL
6	NULL
,	NULL
9	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
taken	NULL
advantage	NULL
of	NULL
IgM	NULL
*	NULL
IgD*	NULL
CL-O01	NULL
cells	NULL
,	NULL
our	NULL
recently	NULL
identified	NULL
human	NULL
monoclonal	NULL
model	NULL
of	NULL
Ig	NULL
class	NULL
switching	NULL
,	NULL
germinal	NULL
center	NULL
(	NULL
GC	NULL
)	NULL
differentiation	NULL
(	NULL
13-15	NULL
)	NULL
,	NULL
and	NULL
somatic	NULL
hypermutation	NULL
(	NULL
33	NULL
)	NULL
,	NULL
to	NULL
address	NULL
the	NULL
functionality	NULL
of	NULL
the	NULL
ECS	NULL
lying	NULL
upstream	NULL
of	NULL
the	NULL
human	NULL
Cy3	NULL
gene	NULL
.	NULL

Upon	NULL
CD40L	NULL
:	NULL
CD40	NULL
engagement	NULL
and	NULL
exposure	NULL
to	NULL
IL-4	NULL
,	NULL
CL-O1	NULL
cells	NULL
initiate	NULL
germline	NULL
I1y3-Cy3	NULL
transcription	NULL
and	NULL
undergo	NULL
Su-Sy3	NULL
DNA	NULL
recombination	NULL
.	NULL

By	NULL
transient	NULL
luciferase	NULL
gene	NULL
reporter	NULL
assays	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
a	NULL
DNA	NULL
fragment	NULL
encompassing	NULL
the	NULL
ECS	NULL
and	NULL
the	NULL
major	NULL
[	NULL
y3	NULL
transcriptional	NULL
initiation	NULL
site	NULL
is	NULL
a	NULL
functional	NULL
promoter	NULL
.	NULL

This	NULL
ECS	NULL
is	NULL
synergistically	NULL
induced	NULL
by	NULL
CD4OL	NULL
and	NULL
IL-4	NULL
through	NULL
the	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

and	NULL
STAT-6	NULL
proteins	NULL
and	NULL
their	NULL
binding	NULL
to	NULL
functionally	NULL
cooperative	NULL
CD4OL	NULL
and	NULL
IL-4	NULL
responsive	NULL
cis	NULL
regulatory	NULL
elements	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
B	NULL
cells	NULL
The	NULL
human	NULL
monoclonal	NULL
IgM	NULL
*	NULL
IgD*	NULL
CL-01	NULL
cell	NULL
line	NULL
has	NULL
been	NULL
described	NULL
(	NULL
13-15	NULL
)	NULL
.	NULL

Tonsillar	NULL
B	NULL
cells	NULL
were	NULL
separated	NULL
by	NULL
Ficoll	NULL
gradient	NULL
and	NULL
rosetting	NULL
with	NULL
2-aminoethylisothiouronium	NULL
bromide-treated	NULL
SRBCs	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Nonroset-ting	NULL
cells	NULL
were	NULL
reacted	NULL
with	NULL
a	NULL
FITC-conjugated	NULL
mouse	NULL
mAb	NULL
to	NULL
human	NULL
IgD	NULL
(	NULL
Southern	NULL
Biotechnology	NULL
Associates	NULL
,	NULL
Birmingham	NULL
,	NULL
AL	NULL
)	NULL
and	NULL
then	NULL
with	NULL
anti-FITC®**	NULL
``	NULL
**	NULL
'	NULL
Microbeads	NULL
(	NULL
Miltenyi	NULL
Biotech	NULL
,	NULL
Auburn	NULL
,	NULL
CA	NULL
)	NULL
to	NULL
positively	NULL
select	NULL
sIgD*	NULL
B	NULL
cells	NULL
using	NULL
the	NULL
MiniMACS	NULL
magnetic	NULL
sorter	NULL
(	NULL
Miltenyi	NULL
Bio-tech	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
heat	NULL
inactivated	NULL
FBS	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
100	NULL
U/ml	NULL
penicillin	NULL
,	NULL
and	NULL
100	NULL
pg/ml	NULL
streptomycin	NULL
.	NULL

Human	NULL
trimeric	NULL
CD4O0L	NULL
leucine-zipper	NULL
fusion	NULL
protein	NULL
(	NULL
htCD4OL	NULL
)	NULL
(	NULL
Immunex	NULL
,	NULL
Se-attle	NULL
,	NULL
WA	NULL
)	NULL
was	NULL
used	NULL
at	NULL
1	NULL
pg/ml	NULL
.	NULL

Recombinant	NULL
human	NULL
IL-4	NULL
(	NULL
Schering	NULL
Plough	NULL
,	NULL
Kenilworth	NULL
,	NULL
NJ	NULL
)	NULL
was	NULL
used	NULL
at	NULL
500	NULL
U/ml	NULL
.	NULL

The	NULL
higher	NULL
amount	NULL
of	NULL
IL-4	NULL
as	NULL
compared	NULL
with	NULL
previous	NULL
experiments	NULL
(	NULL
13-15	NULL
)	NULL
was	NULL
necessary	NULL
to	NULL
optimize	NULL
the	NULL
IL-4-dependent	NULL
response	NULL
in	NULL
transfected	NULL
B	NULL
cells	NULL
.	NULL

PCR	NULL
amplification	NULL
of	NULL
Iy3-Cy3	NULL
,	NULL
V	NULL
,	NULL
,	NULL
DJ	NULL
,	NULL
,	NULL
Cy3	NULL
,	NULL
and	NULL
B-actin	NULL
cDNA	NULL
transcripts	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
3	NULL
X	NULL
10°	NULL
CL-O1	NULL
or	NULL
purified	NULL
tonsillar	NULL
B	NULL
cells	NULL
using	NULL
the	NULL
RNeasy	NULL
Total	NULL
RNA	NULL
Kit	NULL
(	NULL
Qiagen	NULL
,	NULL
Chatsworth	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
then	NULL
reverse	NULL
transcribed	NULL
using	NULL
the	NULL
Superscript	NULL
Preamplification	NULL
System	NULL
for	NULL
first	NULL
strand	NULL
cDNA	NULL
synthesis	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
.	NULL

1y3-Cy3	NULL
,	NULL
V	NULL
;	NULL
,	NULL
DJ	NULL
,	NULL
,	NULL
-Cy3	NULL
,	NULL
and	NULL
B-actin	NULL
transcript	NULL
cDNAs	NULL
were	NULL
PCR	NULL
amplified	NULL
for	NULL
25	NULL
cycles	NULL
as	NULL
described	NULL
(	NULL
13	NULL
,	NULL
15	NULL
)	NULL
.	NULL

HUMAN	NULL
ECS-Iy3	NULL
IS	NULL
A	NULL
FUNCTIONAL	NULL
GENE	NULL
PROMOTER	NULL
Luciferase	NULL
reporter	NULL
vectors	NULL
pGL3-Basic	NULL
,	NULL
pGL3-Promoter	NULL
,	NULL
and	NULL
pRL-CMV	NULL
reporter	NULL
vectors	NULL
were	NULL
from	NULL
Promega	NULL
(	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

The	NULL
-449/+265	NULL
ECS-Iy3	NULL
DNA	NULL
fragment	NULL
was	NULL
PCR	NULL
amplified	NULL
from	NULL
the	NULL
HindII/BamHI	NULL
subclone	NULL
of	NULL
the	NULL
5	NULL
'	NULL
human	NULL
S	NULL
$	NULL
y3	NULL
region	NULL
(	NULL
GenBank	NULL
Accession	NULL
No	NULL
.	NULL

$	NULL
79588	NULL
)	NULL
(	NULL
6	NULL
)	NULL
using	NULL
primers	NULL
with	NULL
5	NULL
'	NULL
overhangs	NULL
containing	NULL
KpnI	NULL
(	NULL
sense	NULL
)	NULL
and	NULL
Bg/lI	NULL
(	NULL
antisense	NULL
)	NULL
sites	NULL
.	NULL

Digested	NULL
PCR	NULL
products	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
pGL3-Basic	NULL
vector	NULL
.	NULL

The	NULL
-352/+265	NULL
,	NULL
-239/	NULL
+265	NULL
,	NULL
-157/+265	NULL
,	NULL
and	NULL
-42/+265	NULL
5	NULL
``	NULL
progressive	NULL
deletional	NULL
mutants	NULL
of	NULL
the	NULL
ECS-Iy3	NULL
sequence	NULL
were	NULL
PCR	NULL
amplified	NULL
using	NULL
appropriate	NULL
sense	NULL
primers	NULL
with	NULL
5	NULL
``	NULL
KpnI	NULL
and	NULL
antisense	NULL
primers	NULL
with	NULL
Bg/lI	NULL
site	NULL
overhangs	NULL
.	NULL

Site-directed	NULL
mutants	NULL
were	NULL
generated	NULL
by	NULL
ligating	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
PCR	NULL
fragments	NULL
flanking	NULL
the	NULL
targeted	NULL
motifs	NULL
.	NULL

The	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
DNA	NULL
fragments	NULL
were	NULL
amplified	NULL
using	NULL
appropriate	NULL
primers	NULL
with	NULL
5	NULL
'	NULL
overhangs	NULL
containing	NULL
KprI	NULL
(	NULL
sense	NULL
)	NULL
/SacI	NULL
(	NULL
antisense	NULL
)	NULL
and	NULL
Sac	NULL
!	NULL

(	NULL
sense	NULL
)	NULL
/Bg/ll	NULL
(	NULL
antisense	NULL
)	NULL
sites	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
amplified	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
DNA	NULL
fragments	NULL
were	NULL
digested	NULL
with	NULL
Kprl/Sacl	NULL
,	NULL
and	NULL
Sacl/BgIl	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
Kpnl/BgllI-digested	NULL
pGL-3-Basic	NULL
vector	NULL
.	NULL

This	NULL
strategy	NULL
disrupted	NULL
the	NULL
targeted	NULL
motif	NULL
by	NULL
replacing	NULL
6	NULL
nucleotides	NULL
of	NULL
the	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
sequence	NULL
with	NULL
a	NULL
Sacl	NULL
restriction	NULL
site	NULL
.	NULL

The	NULL
kB3~	NULL
«	NULL
B4~	NULL
mutant	NULL
was	NULL
generated	NULL
by	NULL
amplifying	NULL
the	NULL
5°	NULL
and	NULL
3	NULL
'	NULL
fragments	NULL
from	NULL
the	NULL
kB3~	NULL
-449/+265	NULL
ECS-Iy3	NULL
pGL3	NULL
construct	NULL
.	NULL

All	NULL
constructs	NULL
were	NULL
analyzed	NULL
by	NULL
digestion	NULL
with	NULL
restriction	NULL
endonucleases	NULL
and	NULL
by	NULL
sequencing	NULL
using	NULL
a	NULL
TagTrack	NULL
DNA	NULL
Sequencing	NULL
System	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Plasmids	NULL
were	NULL
separated	NULL
by	NULL
CsCI	NULL
gradient	NULL
centrifugation	NULL
.	NULL

The	NULL
pGL3-Promoter	NULL
plasmid	NULL
contains	NULL
the	NULL
SV40	NULL
minimal	NULL
promoter	NULL
segment	NULL
.	NULL

DNA	NULL
fragment	NULL
encompassing	NULL
the	NULL
-239/	NULL
-65	NULL
ECS	NULL
sequence	NULL
was	NULL
PCR	NULL
amplified	NULL
from	NULL
the	NULL
wt	NULL
-449/+265	NULL
ECS-Iy3	NULL
pGL3	NULL
template	NULL
.	NULL

Targeted	NULL
mutant	NULL
ECS	NULL
fragments	NULL
were	NULL
amplified	NULL
from	NULL
corresponding	NULL
mutant	NULL
templates	NULL
using	NULL
primers	NULL
with	NULL
5	NULL
'	NULL
overhangs	NULL
containing	NULL
KpnI	NULL
(	NULL
sense	NULL
)	NULL
and	NULL
Bg/ill	NULL
(	NULL
antisense	NULL
)	NULL
sites	NULL
,	NULL
respectively	NULL
.	NULL

Digested	NULL
PCR	NULL
products	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
pGL3-Promoter	NULL
vector	NULL
.	NULL

Transfection	NULL
and	NULL
dual	NULL
luciferase	NULL
assay	NULL
CL-01	NULL
cells	NULL
(	NULL
8	NULL
X	NULL
10°	NULL
)	NULL
in	NULL
500	NULL
ul	NULL
RPMI-FBS	NULL
were	NULL
mixed	NULL
with	NULL
40	NULL
ul	NULL
TE	NULL
(	NULL
50	NULL
mM	NULL
Tris	NULL
,	NULL
10	NULL
mM	NULL
EDTA	NULL
)	NULL
solution	NULL
containing	NULL
20	NULL
ug	NULL
of	NULL
pGL3	NULL
reporter	NULL
construct	NULL
and	NULL
10	NULL
ng	NULL
of	NULL
pRL-CMV	NULL
control	NULL
vector	NULL
.	NULL

Electroporation	NULL
was	NULL
performed	NULL
at	NULL
725	NULL
V/cm	NULL
and	NULL
950	NULL
uF	NULL
using	NULL
a	NULL
Gene	NULL
Pulser	NULL
II	NULL
apparatus	NULL
(	NULL
Bio-Rad	NULL
Laboratories	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Each	NULL
transfection	NULL
was	NULL
performed	NULL
in	NULL
duplicate	NULL
.	NULL

After	NULL
electroporation	NULL
,	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
complete	NULL
medium	NULL
(	NULL
2	NULL
X	NULL
10®/ml	NULL
)	NULL
,	NULL
split	NULL
into	NULL
aliquots	NULL
,	NULL
and	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IL-4	NULL
(	NULL
500	NULL
U/ml	NULL
)	NULL
and/or	NULL
htCD4O0L	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
.	NULL

After	NULL
24	NULL
h	NULL
,	NULL
firefly	NULL
and	NULL
ranilla	NULL
luciferase	NULL
activities	NULL
were	NULL
measured	NULL
using	NULL
the	NULL
Dual-Luciferase	NULL
Assay	NULL
System	NULL
(	NULL
Promega	NULL
)	NULL
to	NULL
assess	NULL
promoter	NULL
activity	NULL
and	NULL
transfection	NULL
efficiency	NULL
,	NULL
respectively	NULL
.	NULL

All	NULL
measures	NULL
were	NULL
corrected	NULL
by	NULL
subtracting	NULL
the	NULL
baseline	NULL
activity	NULL
of	NULL
lysates	NULL
from	NULL
nontransfected	NULL
cells	NULL
.	NULL

Nuclear	NULL
extract	NULL
preparation	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
CL-O01	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
)	NULL
or	NULL
purified	NULL
tonsillar	NULL
(	NULL
10	NULL
'	NULL
)	NULL
B	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
appropriate	NULL
stimuli	NULL
for	NULL
12	NULL
h	NULL
and	NULL
then	NULL
lysed	NULL
to	NULL
extract	NULL
nuclear	NULL
proteins	NULL
according	NULL
to	NULL
a	NULL
modified	NULL
small	NULL
scale	NULL
extraction	NULL
method	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Bradford	NULL
assay	NULL
(	NULL
Bio-Rad	NULL
)	NULL
was	NULL
performed	NULL
to	NULL
determine	NULL
protein	NULL
concentration	NULL
.	NULL

Double	NULL
stranded	NULL
oligonucleotides	NULL
(	NULL
consensus	NULL
sequences	NULL
are	NULL
underlined	NULL
)	NULL
overlapping	NULL
the	NULL
«	NULL
B3	NULL
(	NULL
residues	NULL
-236	NULL
to	NULL
-216	NULL
,	NULL
GTGTCTGGACTC	NULL
CCCCTCGCC	NULL
)	NULL
,	NULL
or	NULL
the	NULL
GAS	NULL
(	NULL
residues	NULL
-96	NULL
to	NULL
-69	NULL
,	NULL
GAGCTGTGATT	NULL
TCCTAGGAAGACAAA	NULL
)	NULL
sites	NULL
were	NULL
end	NULL
labeled	NULL
with	NULL
[	NULL
y-*	NULL
P	NULL
]	NULL
ATP	NULL
by	NULL
T4	NULL
kinase	NULL
and	NULL
used	NULL
at	NULL
approximately	NULL
30,000	NULL
cpm	NULL
in	NULL
each	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
analysis	NULL
(	NULL
EMSA	NULL
)	NULL
reaction	NULL
.	NULL

For	NULL
competition	NULL
,	NULL
the	NULL
following	NULL
double	NULL
stranded	NULL
oligonucleotides	NULL
were	NULL
used	NULL
(	NULL
bold	NULL
face	NULL
letters	NULL
indicate	NULL
mutated	NULL
residues	NULL
)	NULL
:	NULL
Ig	NULL
«	NULL
B	NULL
,	NULL
5-AGCTTCAGAGGGACTTTCCTCTGA-3	NULL
'	NULL
;	NULL
mutant	NULL
Ig	NULL
«	NULL
B	NULL
,	NULL
5-AGCTTCAGAAAAACTTTCCTCTGA-3	NULL
'	NULL
;	NULL
Ie	NULL
GAS	NULL
,	NULL
5-GATC	NULL
CACTTCCCAAGAACAGA-3	NULL
'	NULL
;	NULL
and	NULL
mutant	NULL
Ie	NULL
GAS	NULL
,	NULL
5'-GATCCAC	NULL
CCCCCAAGGCAGA-3	NULL
'	NULL
.	NULL

The	NULL
EMSA	NULL
reaction	NULL
mixtures	NULL
(	NULL
20	NULL
gl	NULL
)	NULL
contained	NULL
1	NULL
ng	NULL
DNA	NULL
probe	NULL
,	NULL
4	NULL
pug	NULL
nuclear	NULL
protein	NULL
extracts	NULL
,	NULL
2	NULL
ug	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
,	NULL
and	NULL
2	NULL
pl	NULL
binding	NULL
buffer	NULL
(	NULL
12.5	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
DDT	NULL
,	NULL
and	NULL
0.05	NULL
%	NULL
Nonidet	NULL
P-40	NULL
)	NULL
.	NULL

The	NULL
reaction	NULL
samples	NULL
were	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
15	NULL
min	NULL
and	NULL
then	NULL
electrophoresed	NULL
through	NULL
a	NULL
6	NULL
%	NULL
nondenaturing	NULL
polyacrylamide	NULL
gel	NULL
in	NULL
0.25	NULL
%	NULL
Tris-borate	NULL
EDTA	NULL
buffer	NULL
at	NULL
150	NULL
V.	NULL
In	NULL
competition	NULL
,	NULL
inhibition	NULL
,	NULL
and	NULL
supershift	NULL
experiments	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
specific	NULL
Abs	NULL
or	NULL
competing	NULL
oligonucleotides	NULL
before	NULL
addition	NULL
of	NULL
the	NULL
radiolabeled	NULL
probe	NULL
.	NULL

Rabbit	NULL
Abs	NULL
to	NULL
human	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
p65	NULL
,	NULL
c-Rel	NULL
,	NULL
Rel	NULL
B	NULL
,	NULL
STAT-3	NULL
,	NULL
STAT-5	NULL
,	NULL
and	NULL
STAT-6	NULL
proteins	NULL
were	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
were	NULL
used	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
1	NULL
pl	NULL
for	NULL
a	NULL
20-pl	NULL
reaction	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
CL-01	NULL
cells	NULL
_	NULL
Naive	NULL
B	NULL
cells	NULL
htCD40L	NULL
(	NULL
0.5	NULL
ug/ml	NULL
)	NULL
_-	NULL
-	NULL
+	NULL
+	NULL
-o-	NULL
t	NULL
+	NULL
IL-4	NULL
(	NULL
500	NULL
U/ml	NULL
)	NULL
_-	NULL
+	NULL
-	NULL
+	NULL
o-	NULL
#	NULL
-o	NULL
+	NULL
--	NULL
Ret	NULL
.	NULL

FIGURE	NULL
1	NULL
.	NULL

Expression	NULL
of	NULL
germline	NULL
I1y3-Cy3	NULL
and	NULL
mature	NULL
transcripts	NULL
by	NULL
Ig	NULL
M*	NULL
IgD*	NULL
CL-01	NULL
and	NULL
normal	NULL
naive	NULL
Ig	NULL
M*	NULL
IgD*	NULL
B	NULL
cells	NULL
.	NULL

CL-01	NULL
and	NULL
naive	NULL
B	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
medium	NULL
only	NULL
,	NULL
or	NULL
in	NULL
medium	NULL
containing	NULL
htCD40L	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
,	NULL
IL-4	NULL
(	NULL
500	NULL
U/ml	NULL
)	NULL
,	NULL
or	NULL
both	NULL
htCD40L	NULL
and	NULL
IL-4	NULL
.	NULL

cDNAs	NULL
from	NULL
cells	NULL
cultured	NULL
for	NULL
2	NULL
or	NULL
5	NULL
days	NULL
were	NULL
used	NULL
as	NULL
templates	NULL
to	NULL
PCR	NULL
amplify	NULL
1y3-Cy3	NULL
(	NULL
670-bp	NULL
)	NULL
and	NULL
V	NULL
,	NULL
;	NULL
,	NULL
DJ	NULL
,	NULL
-Cy3	NULL
(	NULL
416-bp	NULL
)	NULL
transcripts	NULL
,	NULL
respectively	NULL
.	NULL

B-Actin	NULL
cDNA	NULL
was	NULL
amplified	NULL
as	NULL
control	NULL
.	NULL

Amplified	NULL
cDNAs	NULL
were	NULL
fractionated	NULL
through	NULL
a	NULL
1	NULL
%	NULL
ethidium	NULL
bromide	NULL
agarose	NULL
gel	NULL
.	NULL

The	NULL
findings	NULL
depicted	NULL
here	NULL
were	NULL
obtained	NULL
from	NULL
one	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
yielding	NULL
similar	NULL
results	NULL
.	NULL

Results	NULL
Human	NULL
IgM*	NULL
IgD	NULL
'	NULL
B	NULL
cells	NULL
express	NULL
germline	NULL
Iy3-Cy3	NULL
and	NULL
productive	NULL
V	NULL
,	NULL
,	NULL
DJ	NULL
,	NULL
,	NULL
Cy3	NULL
transcripts	NULL
upon	NULL
incubation	NULL
with	NULL
CD4OL	NULL
and	NULL
IL-4	NULL
To	NULL
verify	NULL
the	NULL
relative	NULL
contribution	NULL
of	NULL
CD4OL	NULL
and	NULL
IL-4	NULL
to	NULL
the	NULL
in	NULL
duction	NULL
of	NULL
switching	NULL
to	NULL
Cy3	NULL
,	NULL
IgM	NULL
*	NULL
IgD*	NULL
CL-O1	NULL
cells	NULL
and	NULL
purified	NULL
IgM	NULL
*	NULL
IgD*	NULL
tonsillar	NULL
B	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
medium	NULL
alone	NULL
or	NULL
in	NULL
A	NULL
Hind	NULL
IIl	NULL
Stu	NULL
I	NULL
BamH	NULL
I	NULL
&	NULL
P	NULL
5329	NULL
medium	NULL
containing	NULL
htCD40L	NULL
(	NULL
1	NULL
pug/m	NULL
!	NULL
)	NULL

,	NULL
IL-4	NULL
(	NULL
500	NULL
U/ml	NULL
)	NULL
,	NULL
or	NULL
both	NULL
htCD40L	NULL
and	NULL
IL-4	NULL
.	NULL

cDNAs	NULL
from	NULL
cells	NULL
cultured	NULL
for	NULL
2	NULL
and	NULL
5	NULL
days	NULL
were	NULL
used	NULL
as	NULL
templates	NULL
to	NULL
PCR	NULL
amplify	NULL
germline	NULL
I1y3-Cy3	NULL
(	NULL
670	NULL
bp	NULL
)	NULL
and	NULL
productive	NULL
V	NULL
,	NULL
,	NULL
DJ	NULL
,	NULL
,	NULL
-Cy3	NULL
(	NULL
416	NULL
bp	NULL
)	NULL
transcripts	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
amplified	NULL
cDNAs	NULL
was	NULL
verified	NULL
by	NULL
restriction	NULL
digestion	NULL
and	NULL
sequencing	NULL
(	NULL
13	NULL
)	NULL
.	NULL

B	NULL
cells	NULL
in	NULL
medium	NULL
alone	NULL
failed	NULL
to	NULL
express	NULL
germline	NULL
1y3-Cy3	NULL
and	NULL
productive	NULL
V	NULL
,	NULL
,	NULL
DJ	NULL
,	NULL
,	NULL
-Cy3	NULL
transcripts	NULL
.	NULL

htCD40L	NULL
or	NULL
IL-4	NULL
alone	NULL
were	NULL
sufficient	NULL
to	NULL
initiate	NULL
1y3-Cy3	NULL
transcription	NULL
,	NULL
but	NULL
not	NULL
switch	NULL
DNA	NULL
recombination	NULL
to	NULL
Cy3	NULL
,	NULL
as	NULL
V	NULL
,	NULL
,	NULL
DJ	NULL
,	NULL
,	NULL
Cy3	NULL
transcripts	NULL
were	NULL
not	NULL
detected	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
our	NULL
previous	NULL
findings	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
htCD4OL	NULL
and	NULL
IL-4	NULL
synergistically	NULL
up-regulated	NULL
the	NULL
expression	NULL
of	NULL
germline	NULL
I1y3-Cy3	NULL
transcripts	NULL
and	NULL
induced	NULL
related	NULL
DNA	NULL
recombination	NULL
,	NULL
as	NULL
indicated	NULL
by	NULL
the	NULL
detection	NULL
of	NULL
both	NULL
V	NULL
,	NULL
,	NULL
DJ	NULL
,	NULL
,	NULL
-Cy3	NULL
transcripts	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
and	NULL
Sy3-Sp	NULL
switch	NULL
circles	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
,	NULL
exposure	NULL
to	NULL
CD4O0L	NULL
or	NULL
IL-4	NULL
is	NULL
sufficient	NULL
to	NULL
induce	NULL
Cy3	NULL
germline	NULL
transcription	NULL
,	NULL
but	NULL
switching	NULL
to	NULL
Cy3	NULL
requires	NULL
both	NULL
CD4OL	NULL
and	NULL
IL-4	NULL
.	NULL

The	NULL
human	NULL
ECS-Iy3	NULL
sequence	NULL
upstream	NULL
of	NULL
Sy3	NULL
contains	NULL
putative	NULL
CD4OL	NULL
and	NULL
IL-4	NULL
REs	NULL
Previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
mouse	NULL
Cy1	NULL
and	NULL
the	NULL
mouse	NULL
and	NULL
the	NULL
human	NULL
Ce	NULL
gene	NULL
promoters	NULL
are	NULL
highly	NULL
dependent	NULL
on	NULL
binding	NULL
sites	NULL
for	NULL
C/EBP	NULL
,	NULL
BSAP	NULL
,	NULL
and	NULL
STAT-6	NULL
(	NULL
NF-IL-4	NULL
)	NULL
transcription	NULL
factors	NULL
(	NULL
17	NULL
,	NULL
19	NULL
,	NULL
20	NULL
,	NULL
28	NULL
,	NULL
34	NULL
,	NULL
35	NULL
)	NULL
.	NULL

The	NULL
ECS-Iy	NULL
sequences	NULL
upstream	NULL
of	NULL
the	NULL
human	NULL
Sy	NULL
regions	NULL
show	NULL
a	NULL
high	NULL
degree	NULL
of	NULL
conservation	NULL
among	NULL
all	NULL
four	NULL
Cy	NULL
isotypes	NULL
and	NULL
are	NULL
highly	NULL
homologous	NULL
in	NULL
the	NULL
ECS	NULL
region	NULL
to	NULL
the	NULL
mouse	NULL
Cy	NULL
promoters	NULL
(	NULL
6	NULL
,	NULL
9	NULL
)	NULL
.	NULL

An	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
ECS-Iy3	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
allowed	NULL
us	NULL
to	NULL
identify	NULL
putative	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
following	NULL
transcription	NULL
factors	NULL
,	NULL
from	NULL
5	NULL
'	NULL
to	NULL
3	NULL
'	NULL
:	NULL
six	NULL
kB	NULL
(	NULL
«	NULL
B1	NULL
to	NULL
<	NULL
B6	NULL
)	NULL
,	NULL
a	NULL
C/EBP	NULL
,	NULL
a	NULL
BSAP	NULL
,	NULL
and	NULL
a	NULL
GAS	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

The	NULL
three	NULL
«	NULL
B	NULL
sites	NULL
(	NULL
B3	NULL
,	NULL
«	NULL
B4	NULL
,	NULL
SY3	NULL
Pvu	NULL
II	NULL
Hind	NULL
IMI	NULL
C73	NULL
B	NULL
-449	NULL
+265	NULL
-449	NULL
¥	NULL
B1	NULL
B2	NULL
&	NULL
*	NULL
«	NULL
+	NULL
%	NULL
%	NULL
»	NULL
%	NULL
&	NULL
%	NULL
&	NULL
+	NULL
F	NULL
+	NULL
AAccmTcacATGAGAGGCCChGeTATTGAGAGGCTGAGACCACGGGCAGAATGGTCATAATCGTTECCAGTCTCAGTCCAGCCCCAGGGACTCAGACACAGAGAAAAGAGCAGCACACAAGGTCdGGecrceccchcertcreccereact	NULL
-	NULL
-299	NULL
Hind	NULL
WI	NULL
-239	NULL
ao	NULL
a	NULL
a	NULL
Yo	NULL
830,000	NULL
|	NULL
x84	NULL
,	NULL
ISRE	NULL
/	NULL
«	NULL
BS/C-EBP	NULL
,	NULL
_	NULL
ATGGGGcAGTATGGeeecaGCCACcACTCccaTCcccacacAcccaTeaGecaccercacctore	NULL
Acrect	NULL
comcreacachcaaaccaccadaacana	NULL
,	NULL
Mummecsccmmum	NULL
-149	NULL
-65	NULL
+1	NULL
BSAP	NULL
&	NULL
R	NULL
,	NULL
_	NULL
GAS	NULL
2	NULL
¥	NULL
_.	NULL
,	NULL
_	NULL
xB6	NULL
,	NULL
&	NULL
&	NULL
&	NULL
-	NULL
>	NULL
{	NULL
GGGCTGCccacaToTAcCTCGCCACAACAGGAAGGGCTEAGACCCCCAC	NULL
42	NULL
«	NULL
«	NULL
«	NULL
*	NULL
%	NULL
*	NULL
«	NULL
&	NULL
a	NULL
*	NULL
*	NULL
*	NULL
+	NULL
«	NULL
CTCGSTGAGTGGGGTCAGCACAGCCCAGGAGCACAGGCTCAGGAGCACA	NULL
AGCACAGAGCC	NULL
TEGGECGCAGCCATCGSCECTCC	NULL
TGGACC	NULL
TGAGCTGC	NULL
TGAACAGGCTGCAAGAGECTGECCAGAGECTGGGGCGAGECCAGCCCCACATEG	NULL
+1	NULL
S	NULL
l	NULL
«	NULL
+265	NULL
200	NULL
Y	NULL
.	NULL

-	NULL
a	NULL
+	NULL
+	NULL
*	NULL
+	NULL
»	NULL
a	NULL
«	NULL
AAGCCTAAGCGGAGCCAGCACGGGGGAGGTGGGCAGGCTTCAGGCACCGATGCCCACCCAGTGCGAGACGACGGGGACCGTEGECAGEECCTTCCAAGCCAACAGGGCAGGACACACCAGAGGECTGACTGAGGCCT	NULL
+2	NULL
8	NULL
8	NULL
Stud	NULL
FIGURE	NULL
2	NULL
.	NULL

A	NULL
,	NULL
Germline	NULL
configuration	NULL
and	NULL
restriction	NULL
map	NULL
of	NULL
the	NULL
DNA	NULL
region	NULL
upstream	NULL
of	NULL
the	NULL
human	NULL
Cy3	NULL
gene	NULL
,	NULL
and	NULL
encompassing	NULL
the	NULL
ECS	NULL
,	NULL
the	NULL
1y3	NULL
exon	NULL
,	NULL
the	NULL
Sy3	NULL
region	NULL
,	NULL
and	NULL
the	NULL
Cy3	NULL
gene	NULL
.	NULL

Arrowheads	NULL
indicate	NULL
the	NULL
DNA	NULL
fragment	NULL
(	NULL
from	NULL
residue	NULL
-449	NULL
to	NULL
residue	NULL
+265	NULL
,	NULL
where	NULL
+1	NULL
marks	NULL
the	NULL
major	NULL
1y3	NULL
transcriptional	NULL
initiation	NULL
site	NULL
)	NULL
cloned	NULL
into	NULL
the	NULL
pGL3-Basic	NULL
reporter	NULL
vector	NULL
.	NULL

B	NULL
,	NULL
Sequence	NULL
of	NULL
the	NULL
HindII-Stul	NULL
ECS-Iy3	NULL
region	NULL
(	NULL
residues	NULL
-449	NULL
to	NULL
+288	NULL
)	NULL
.	NULL

The	NULL
HindIII	NULL
and	NULL
Stul	NULL
restriction	NULL
sites	NULL
are	NULL
underlined	NULL
,	NULL
and	NULL
arrowheads	NULL
mark	NULL
the	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
ends	NULL
of	NULL
the	NULL
DNA	NULL
segment	NULL
cloned	NULL
into	NULL
the	NULL
pGL3-Basic	NULL
vector	NULL
(	NULL
-449/+265	NULL
ECS-Iy3	NULL
region	NULL
)	NULL
and	NULL
that	NULL
of	NULL
the	NULL
ECS	NULL
(	NULL
-239/-65	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
major	NULL
1y3	NULL
transcriptional	NULL
initiation	NULL
site	NULL
(	NULL
32	NULL
)	NULL
is	NULL
marked	NULL
by	NULL
a	NULL
turned	NULL
arrow	NULL
.	NULL

The	NULL
ECS	NULL
is	NULL
shaded	NULL
,	NULL
and	NULL
the	NULL
putative	NULL
transcription	NULL
factor	NULL
binding	NULL
motifs	NULL
are	NULL
boxed	NULL
.	NULL

The	NULL
consensus	NULL
sequences	NULL
for	NULL
the	NULL
depicted	NULL
motifs	NULL
are	NULL
detailed	NULL
in	NULL
the	NULL
text	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
5330	NULL
Relative	NULL
light	NULL
units	NULL
hiCDAOL	NULL
>	NULL
o	NULL
#	NULL
>	NULL
o	NULL
t+	NULL
>	NULL
o	NULL
+	NULL
-	NULL
0+	NULL
IL-4	NULL
-	NULL
-	NULL
+	NULL
+	NULL
-	NULL
-	NULL
+	NULL
+	NULL
-449/+265	NULL
ECS-Iy3	NULL
pGL3	NULL
pGL3-Basic	NULL
HUMAN	NULL
ECS-Iy3	NULL
IS	NULL
A	NULL
FUNCTIONAL	NULL
GENE	NULL
PROMOTER	NULL
B	NULL
Fold	NULL
induction	NULL
0	NULL
htCD40L	NULL
so	NULL
+	NULL
IL-4	NULL
e	NULL
-449/+265	NULL
ECS-1y3	NULL
pGL3	NULL
FIGURE	NULL
3	NULL
.	NULL

Inducibility	NULL
of	NULL
the	NULL
human	NULL
ECS-Iy3	NULL
region	NULL
by	NULL
htCD40L	NULL
and/or	NULL
IL-4	NULL
.	NULL

CL-01	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
either	NULL
the	NULL
empty	NULL
pGL-3-Basic	NULL
vector	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
or	NULL
the	NULL
ECS-Iy3-pGL-3	NULL
vector	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
.	NULL

pRL-CMV	NULL
control	NULL
plasmid	NULL
(	NULL
10	NULL
ng	NULL
)	NULL
was	NULL
cotransfected	NULL
with	NULL
the	NULL
reporter	NULL
constructs	NULL
to	NULL
normalize	NULL
the	NULL
transfection	NULL
efficiency	NULL
.	NULL

Transfected	NULL
CL-01	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
medium	NULL
only	NULL
,	NULL
or	NULL
in	NULL
medium	NULL
containing	NULL
htCD40L	NULL
,	NULL
IL-4	NULL
,	NULL
or	NULL
both	NULL
htCD40L	NULL
and	NULL
IL-4	NULL
,	NULL
and	NULL
the	NULL
luciferase	NULL
gene	NULL
activity	NULL
was	NULL
assessed	NULL
after	NULL
24	NULL
h.	NULL
Data	NULL
are	NULL
expressed	NULL
as	NULL
relative	NULL
light	NULL
units	NULL
normalized	NULL
to	NULL
a	NULL
cotransfected	NULL
pRL-CMV	NULL
control	NULL
plasmid	NULL
(	NULL
A	NULL
)	NULL
,	NULL
and	NULL
as	NULL
fold	NULL
induction	NULL
(	NULL
B	NULL
)	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
ratio	NULL
of	NULL
the	NULL
luciferase	NULL
activity	NULL
of	NULL
extracts	NULL
from	NULL
induced	NULL
cells	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
extracts	NULL
from	NULL
cells	NULL
incubated	NULL
in	NULL
medium	NULL
only	NULL
.	NULL

Results	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
three	NULL
independent	NULL
transfection	NULL
experiments	NULL
.	NULL

and	NULL
«	NULL
B5	NULL
)	NULL
within	NULL
the	NULL
Cy3	NULL
ECS	NULL
are	NULL
collinear	NULL
with	NULL
the	NULL
CD40	NULL
RE	NULL
of	NULL
the	NULL
mouse	NULL
Cy1	NULL
promoter	NULL
(	NULL
19	NULL
)	NULL
.	NULL

The	NULL
palindromic	NULL
GAS	NULL
site	NULL
,	NULL
also	NULL
located	NULL
within	NULL
the	NULL
ECS	NULL
,	NULL
contains	NULL
a	NULL
core	NULL
spacer	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
IL-4	NULL
RE	NULL
of	NULL
the	NULL
human	NULL
Ce	NULL
and	NULL
CD23	NULL
gene	NULL
promoters	NULL
(	NULL
25	NULL
,	NULL
26	NULL
,	NULL
36	NULL
)	NULL
.	NULL

The	NULL
ECS-Iy3	NULL
region	NULL
is	NULL
a	NULL
functional	NULL
promoter	NULL
that	NULL
is	NULL
synergistically	NULL
induced	NULL
by	NULL
CD4OL	NULL
and	NULL
IL-4	NULL
The	NULL
CD4O0L	NULL
and	NULL
IL-4-dependent	NULL
inducibility	NULL
of	NULL
a	NULL
714-bp	NULL
DNA	NULL
fragment	NULL
encompassing	NULL
the	NULL
ECS	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
major	NULL
1y3	NULL
transcriptional	NULL
initiation	NULL
site	NULL
(	NULL
ECS-I	NULL
[	NULL
y3	NULL
region	NULL
,	NULL
residues	NULL
-449	NULL
to	NULL
+265	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
,	NULL
was	NULL
tested	NULL
in	NULL
luciferase	NULL
reporter	NULL
assays	NULL
after	NULL
insertion	NULL
of	NULL
this	NULL
DNA	NULL
fragment	NULL
into	NULL
the	NULL
pGL3	NULL
vector	NULL
,	NULL
and	NULL
transient	NULL
transfection	NULL
of	NULL
CL-O01	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

ECS-Iy3-pGL-3-transfected	NULL
CL-O1	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
medium	NULL
alone	NULL
or	NULL
in	NULL
medium	NULL
containing	NULL
htCD4O0L	NULL
(	NULL
1	NULL
pg/m	NULL
!	NULL

1	NULL
)	NULL
,	NULL
IL-4	NULL
(	NULL
500	NULL
U/m1	NULL
)	NULL
,	NULL
or	NULL
both	NULL
htCD4OL	NULL
and	NULL
IL-4	NULL
.	NULL

After	NULL
24	NULL
h	NULL
,	NULL
the	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
.	NULL

Upon	NULL
exposure	NULL
to	NULL
htCD40L	NULL
or	NULL
IL-4	NULL
,	NULL
luciferase	NULL
activity	NULL
was	NULL
induced	NULL
in	NULL
CL-O1	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
ECS-Iy3-pGL3	NULL
,	NULL
but	NULL
not	NULL
the	NULL
pGL3-Basic	NULL
vector	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

This	NULL
induction	NULL
was	NULL
synergistically	NULL
enhanced	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
htCD4OL	NULL
and	NULL
IL-4	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
ECS-1y3-pGL3	NULL
construct	NULL
displayed	NULL
a	NULL
basal	NULL
activity	NULL
lower	NULL
than	NULL
that	NULL
associated	NULL
with	NULL
the	NULL
empty	NULL
pGL3-Basic	NULL
vector	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
tested	NULL
DNA	NULL
fragment	NULL
contains	NULL
a	NULL
potent	NULL
silencer	NULL
region	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
human	NULL
ECS-Iy3	NULL
region	NULL
possesses	NULL
a	NULL
tran-scription-promoting	NULL
activity	NULL
that	NULL
is	NULL
inducible	NULL
by	NULL
either	NULL
CD4OL	NULL
or	NULL
IL-4	NULL
and	NULL
that	NULL
is	NULL
synergistically	NULL
enhanced	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
CD40L	NULL
and	NULL
IL-4	NULL
.	NULL

The	NULL
-239/-157	NULL
ECS	NULL
is	NULL
critical	NULL
in	NULL
conferring	NULL
both	NULL
CD4OL	NULL
and	NULL
IL-4-dependent	NULL
transcriptional	NULL
inducibility	NULL
to	NULL
the	NULL
ECS-Iy3	NULL
region	NULL
To	NULL
narrow	NULL
down	NULL
the	NULL
portion	NULL
of	NULL
the	NULL
ECS-Iy3	NULL
region	NULL
involved	NULL
in	NULL
the	NULL
CD40L	NULL
and	NULL
IL-4	NULL
inducibility	NULL
,	NULL
5	NULL
'	NULL
progressive	NULL
D1	NULL
,	NULL
D2	NULL
,	NULL
D3	NULL
,	NULL
and	NULL
D4	NULL
ECS-Iy3	NULL
deletion	NULL
mutants	NULL
were	NULL
generated	NULL
by	NULL
taking	NULL
into	NULL
consideration	NULL
the	NULL
distribution	NULL
of	NULL
the	NULL
putative	NULL
«	NULL
B	NULL
,	NULL
BSAP	NULL
,	NULL
and	NULL
GAS	NULL
sites	NULL
(	NULL
Figs	NULL
.	NULL

2B	NULL
and	NULL
4	NULL
)	NULL
.	NULL

These	NULL
deletion	NULL
mutants	NULL
were	NULL
separately	NULL
inserted	NULL
into	NULL
pGL3	NULL
vectors	NULL
that	NULL
were	NULL
used	NULL
to	NULL
transfect	NULL
CL-O1	NULL
cells	NULL
.	NULL

Transfected	NULL
CL-O1	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
medium	NULL
only	NULL
,	NULL
or	NULL
in	NULL
medium	NULL
containing	NULL
htCD4O0L	NULL
,	NULL
IL-4	NULL
,	NULL
or	NULL
both	NULL
,	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
24	NULL
h	NULL
later	NULL
.	NULL

Notably	NULL
,	NULL
while	NULL
the	NULL
D1	NULL
and	NULL
D2	NULL
mutants	NULL
displayed	NULL
a	NULL
basal	NULL
reporter	NULL
activity	NULL
comparable	NULL
to	NULL
that	NULL
associated	NULL
with	NULL
the	NULL
ECS-Iy3-pGL3	NULL
construct	NULL
,	NULL
the	NULL
D3	NULL
and	NULL
D4	NULL
mutants	NULL
displayed	NULL
a	NULL
3.9-fold	NULL
lower	NULL
and	NULL
a	NULL
4.5-fold	NULL
higher	NULL
basal	NULL
reporter	NULL
activity	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
,	NULL
while	NULL
the	NULL
-239/-157	NULL
ECS	NULL
fragment	NULL
is	NULL
critical	NULL
in	NULL
conferring	NULL
basal	NULL
transcriptional	NULL
activity	NULL
to	NULL
the	NULL
ECS-Iy3	NULL
sequence	NULL
,	NULL
the	NULL
-157/-65	NULL
ECS	NULL
fragment	NULL
contains	NULL
a	NULL
silencer	NULL
element	NULL
.	NULL

When	NULL
compared	NULL
with	NULL
the	NULL
wt	NULL
ECS-Iy3	NULL
region	NULL
,	NULL
the	NULL
D1	NULL
and	NULL
D2	NULL
mutants	NULL
retained	NULL
full	NULL
htCD4OL-	NULL
or	NULL
IL-4-dependent	NULL
inducibility	NULL
but	NULL
showed	NULL
significantly	NULL
reduced	NULL
synergistic	NULL
responsiveness	NULL
to	NULL
the	NULL
combined	NULL
htCD40L	NULL
and	NULL
IL-4	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
D3	NULL
and	NULL
D4	NULL
mutants	NULL
,	NULL
which	NULL
lacked	NULL
the	NULL
5	NULL
'	NULL
half	NULL
or	NULL
the	NULL
whole	NULL
ECS	NULL
,	NULL
did	NULL
not	NULL
respond	NULL
to	NULL
either	NULL
htCD4O0L	NULL
,	NULL
IL-4	NULL
,	NULL
or	NULL
both	NULL
htCD40L	NULL
and	NULL
IL-4	NULL
.	NULL

All	NULL
together	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
-239	NULL
to	NULL
-157	NULL
region	NULL
of	NULL
the	NULL
ECS	NULL
is	NULL
crucial	NULL
to	NULL
confer	NULL
both	NULL
CD4O0L	NULL
and	NULL
IL-4-dependent	NULL
transcriptional	NULL
inducibility	NULL
to	NULL
the	NULL
ECS-Iy3	NULL
sequence	NULL
and	NULL
that	NULL
elements	NULL
located	NULL
upstream	NULL
of	NULL
the	NULL
ECS	NULL
(	NULL
residues	NULL
-449	NULL
to	NULL
-352	NULL
)	NULL
are	NULL
necessary	NULL
for	NULL
a	NULL
full	NULL
synergistic	NULL
response	NULL
to	NULL
CD4OL	NULL
and	NULL
IL-4	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
CD4OL	NULL
and	NULL
IL-4	NULL
REs	NULL
within	NULL
the	NULL
ECS-Iy3	NULL
region	NULL
To	NULL
identify	NULL
the	NULL
CD4OL	NULL
and	NULL
the	NULL
IL-4	NULL
responsive	NULL
cis	NULL
regulatory	NULL
elements	NULL
within	NULL
the	NULL
ECS	NULL
,	NULL
we	NULL
generated	NULL
ECS-Iy3	NULL
(	NULL
residues	NULL
-449	NULL
to	NULL
+265	NULL
)	NULL
mutants	NULL
bearing	NULL
mutated	NULL
«	NULL
B3	NULL
(	NULL
«	NULL
B3	NULL
)	NULL
,	NULL
«	NULL
B4	NULL
(	NULL
«	NULL
B4	NULL
)	NULL
,	NULL
ISRE/	NULL
kB5/C/EBP	NULL
(	NULL
ISRE	NULL
/kB5	NULL
°	NULL
/C/EBP	NULL
)	NULL
,	NULL
«	NULL
B3/kB4	NULL
(	NULL
«	NULL
B3	NULL
/kB4~	NULL
)	NULL
,	NULL
BSAP	NULL
C	NULL
)	NULL
,	NULL
or	NULL
GAS	NULL
(	NULL
GAST	NULL
)	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

CL-O1	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
wt	NULL
or	NULL
mutated	NULL
ECS-Iy3-pGL3	NULL
constructs	NULL
,	NULL
and	NULL
incubated	NULL
in	NULL
medium	NULL
only	NULL
,	NULL
or	NULL
in	NULL
medium	NULL
containing	NULL
htCD40L	NULL
,	NULL
IL-4	NULL
,	NULL
or	NULL
both	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
measured	NULL
after	NULL
24	NULL
h.	NULL
The	NULL
basal	NULL
reporter	NULL
activity	NULL
of	NULL
«	NULL
B3	NULL
,	NULL
ISRE	NULL
/kB5	NULL
/C/EBP_	NULL
,	NULL
BSAP	NULL
,	NULL
or	NULL
GAS_	NULL
mutated	NULL
constructs	NULL
was	NULL
comparable	NULL
to	NULL
that	NULL
of	NULL
the	NULL
wt	NULL
ECS-Iy3	NULL
construct	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
left	NULL
panel	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
«	NULL
B4~	NULL
and	NULL
the	NULL
«	NULL
B3	NULL
/kB4~	NULL
mutants	NULL
displayed	NULL
a	NULL
4-fold	NULL
lower	NULL
basal	NULL
transcriptional	NULL
activity	NULL
as	NULL
compared	NULL
with	NULL
that	NULL
associated	NULL
with	NULL
the	NULL
wt	NULL
ECS-Iy3	NULL
sequence	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
«	NULL
B4	NULL
site	NULL
is	NULL
critical	NULL
for	NULL
the	NULL
basal	NULL
promoter	NULL
activity	NULL
.	NULL

Compared	NULL
with	NULL
the	NULL
wt	NULL
construct	NULL
,	NULL
the	NULL
«	NULL
B3	NULL
,	NULL
«	NULL
B4	NULL
,	NULL
and	NULL
«	NULL
B3	NULL
/kB4~	NULL
mutants	NULL
,	NULL
but	NULL
not	NULL
the	NULL
ISRE	NULL
/kB5	NULL
/C/	NULL
EBP	NULL
,	NULL
BSAP	NULL
,	NULL
and	NULL
GAS_	NULL
mutants	NULL
,	NULL
reduced	NULL
the	NULL
htCD40L-dependent	NULL
inducibility	NULL
by	NULL
45	NULL
%	NULL
,	NULL
20	NULL
%	NULL
,	NULL
and	NULL
95	NULL
%	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
second	NULL
left	NULL
panel	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
tandem	NULL
«	NULL
B3	NULL
and	NULL
«	NULL
B4	NULL
sites	NULL
constitute	NULL
the	NULL
CD40	NULL
RE	NULL
of	NULL
the	NULL
ECS-Iy3	NULL
region	NULL
.	NULL

Compared	NULL
with	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
5331	NULL
[	NULL
]	NULL
-	NULL
medium	NULL
alone	NULL
&	NULL
ics	NULL
7	NULL
]	NULL
hiCD40L	NULL
B	NULL
hmco4or+	NULL
IL	NULL
-449	NULL
-352	NULL
-239	NULL
-157	NULL
-65	NULL
+265	NULL
L	NULL
.	NULL

|	NULL
w	NULL
.	NULL

/k	NULL
]	NULL
BI	NULL
kB2	NULL
xB	NULL
BSAP	NULL
GAS	NULL
B6	NULL
345	NULL
ECS	NULL
DI	NULL
-—mmma——QA—E	NULL
D2	NULL
D3	NULL
D4	NULL
O	NULL
5	NULL
Relative	NULL
light	NULL
units	NULL
T	NULL
*	NULL
1	NULL
*	NULL
I	NULL
*	NULL
1	NULL
100	NULL
150	NULL
200	NULL
250	NULL
0	NULL
5	NULL
10	NULL
15	NULL
20	NULL
25	NULL
Fold	NULL
induction	NULL
FIGURE	NULL
4	NULL
.	NULL

-	NULL
Approximate	NULL
location	NULL
of	NULL
the	NULL
CD40	NULL
and	NULL
IL-4	NULL
REs	NULL
within	NULL
the	NULL
ECS-Iy3	NULL
region	NULL
.	NULL

Diagrams	NULL
depict	NULL
the	NULL
configuration	NULL
of	NULL
wt	NULL
-449/+265	NULL
ECS-Iy3	NULL
region	NULL
,	NULL
and	NULL
-352/+265	NULL
D1	NULL
,	NULL
-239/+265	NULL
D2	NULL
,	NULL
-157/+265	NULL
D3	NULL
,	NULL
or	NULL
-42/+265	NULL
D4	NULL
5	NULL
``	NULL
progressive	NULL
deletional	NULL
mutants	NULL
.	NULL

Boxes	NULL
correspond	NULL
to	NULL
putative	NULL
«	NULL
B	NULL
(	NULL
«	NULL
B1	NULL
to	NULL
«	NULL
B6	NULL
)	NULL
,	NULL
BSAP	NULL
and	NULL
GAS	NULL
sites	NULL
.	NULL

Turned	NULL
arrow	NULL
marks	NULL
the	NULL
major	NULL
1y3	NULL
transcriptional	NULL
initiation	NULL
site	NULL
(	NULL
32	NULL
)	NULL
.	NULL

The	NULL
names	NULL
and	NULL
the	NULL
schematic	NULL
structure	NULL
of	NULL
the	NULL
plasmids	NULL
are	NULL
indicated	NULL
.	NULL

Reporter	NULL
vectors	NULL
containing	NULL
the	NULL
wt	NULL
or	NULL
mutated	NULL
ECS-Iy3	NULL
region	NULL
were	NULL
electroporated	NULL
into	NULL
CL-O1	NULL
cells	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
then	NULL
incubated	NULL
in	NULL
medium	NULL
only	NULL
,	NULL
or	NULL
in	NULL
medium	NULL
containing	NULL
htCD4O0L	NULL
,	NULL
IL-4	NULL
,	NULL
or	NULL
both	NULL
htCD40L	NULL
and	NULL
IL-4	NULL
,	NULL
and	NULL
the	NULL
luciferase	NULL
gene	NULL
activity	NULL
was	NULL
assessed	NULL
after	NULL
24	NULL
h.	NULL
Data	NULL
are	NULL
expressed	NULL
as	NULL
relative	NULL
light	NULL
units	NULL
(	NULL
Zeft	NULL
pare	NULL
?	NULL
)	NULL

and	NULL
fold	NULL
induction	NULL
(	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

Results	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
three	NULL
independent	NULL
transfection	NULL
experiments	NULL
.	NULL

the	NULL
wt	NULL
construct	NULL
,	NULL
the	NULL
«	NULL
B3	NULL
and	NULL
the	NULL
«	NULL
B3	NULL
/kB4~	NULL
mutants	NULL
reduced	NULL
the	NULL
IL-4-dependent	NULL
inducibility	NULL
by	NULL
75	NULL
%	NULL
and	NULL
98	NULL
%	NULL
,	NULL
respectively	NULL
,	NULL
whereas	NULL
the	NULL
«	NULL
B4~	NULL
and	NULL
BSAP_	NULL
mutants	NULL
showed	NULL
a	NULL
25	NULL
%	NULL
and	NULL
50	NULL
%	NULL
reduction	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
second	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
virtual	NULL
abrogation	NULL
of	NULL
the	NULL
IL-4	NULL
inducibility	NULL
in	NULL
the	NULL
GAS~	NULL
and	NULL
«	NULL
B3	NULL
/	NULL
xB4~	NULL
mutants	NULL
,	NULL
but	NULL
not	NULL
in	NULL
the	NULL
ISRE	NULL
/kB5	NULL
/C/EBP	NULL
,	NULL
and	NULL
BSAP_	NULL
mutants	NULL
,	NULL
suggested	NULL
that	NULL
the	NULL
IL-4	NULL
RE	NULL
encompasses	NULL
the	NULL
GAS	NULL
site	NULL
as	NULL
well	NULL
as	NULL
the	NULL
«	NULL
B3	NULL
and	NULL
«	NULL
B4	NULL
elements	NULL
within	NULL
the	NULL
ECS-Iy3	NULL
region	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
the	NULL
B3	NULL
,	NULL
the	NULL
«	NULL
B3	NULL
/kB4	NULL
,	NULL
or	NULL
the	NULL
GAS	NULL
_	NULL
,	NULL
but	NULL
not	NULL
the	NULL
ISRE~-/kB5	NULL
-	NULL
/C/EBP_	NULL
or	NULL
BSAP_	NULL
mutants	NULL
displayed	NULL
a	NULL
complete	NULL
loss	NULL
of	NULL
the	NULL
synergistic	NULL
activation	NULL
elicited	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
htCD40L	NULL
and	NULL
IL-4	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

Mutations	NULL
disrupting	NULL
the	NULL
BSAP	NULL
binding	NULL
consensus	NULL
element	NULL
reduced	NULL
the	NULL
synergistic	NULL
inducibility	NULL
by	NULL
about	NULL
50	NULL
%	NULL
.	NULL

By	NULL
demonstrating	NULL
that	NULL
the	NULL
CD40	NULL
RE	NULL
consists	NULL
of	NULL
the	NULL
«	NULL
B3	NULL
and	NULL
«	NULL
B4	NULL
sites	NULL
and	NULL
that	NULL
the	NULL
IL-4	NULL
RE	NULL
encompasses	NULL
not	NULL
only	NULL
the	NULL
GAS	NULL
,	NULL
but	NULL
also	NULL
the	NULL
«	NULL
B3/xB4	NULL
sites	NULL
,	NULL
these	NULL
experiments	NULL
define	NULL
partially	NULL
overlapping	NULL
CD40	NULL
and	NULL
IL-4	NULL
REs	NULL
within	NULL
the	NULL
ECS-Iy3	NULL
.	NULL

The	NULL
BSAP	NULL
binding	NULL
consensus	NULL
element	NULL
enhances	NULL
the	NULL
IL-4	NULL
and	NULL
CD40L	NULL
plus	NULL
IL-4-induced	NULL
,	NULL
but	NULL
not	NULL
the	NULL
CD4O0L-induced	NULL
,	NULL
activation	NULL
of	NULL
the	NULL
ECS-Iy3	NULL
sequence	NULL
.	NULL

The	NULL
isolated	NULL
ECS	NULL
fragment	NULL
is	NULL
sufficient	NULL
to	NULL
confer	NULL
CD4OL	NULL
and	NULL
IL-4	NULL
responsiveness	NULL
to	NULL
a	NULL
heterologous	NULL
promoter	NULL
To	NULL
verify	NULL
the	NULL
principal	NULL
function	NULL
of	NULL
the	NULL
«	NULL
B3	NULL
,	NULL
«	NULL
B4	NULL
,	NULL
BSAP	NULL
,	NULL
and	NULL
GAS	NULL
sites	NULL
within	NULL
the	NULL
Cy3	NULL
ECS	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
wt	NULL
,	NULL
«	NULL
B3	NULL
/kB4	NULL
,	NULL
BSAP_	NULL
,	NULL
and	NULL
GAS_-	NULL
ECS	NULL
fragments	NULL
to	NULL
confer	NULL
CD40L	NULL
and/or	NULL
IL-4	NULL
inducibility	NULL
to	NULL
the	NULL
SV40	NULL
minimal	NULL
promoter-driven	NULL
reporter	NULL
construct	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

An	NULL
SV40-pGL3	NULL
reporter	NULL
construct	NULL
lacking	NULL
the	NULL
ECS	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
.	NULL

CL-O1	NULL
cells	NULL
were	NULL
independently	NULL
transfected	NULL
with	NULL
each	NULL
of	NULL
these	NULL
constructs	NULL
and	NULL
incu-	NULL
bated	NULL
in	NULL
medium	NULL
alone	NULL
,	NULL
or	NULL
in	NULL
medium	NULL
containing	NULL
htCD4O0L	NULL
,	NULL
IL-4	NULL
,	NULL
or	NULL
both	NULL
.	NULL

The	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
after	NULL
24	NULL
h	NULL
and	NULL
expressed	NULL
as	NULL
relative	NULL
light	NULL
units	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
left	NULL
panel	NULL
)	NULL
,	NULL
and	NULL
as	NULL
fold	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
basal	NULL
reporter	NULL
activities	NULL
displayed	NULL
by	NULL
the	NULL
«	NULL
B3	NULL
/kB4~	NULL
,	NULL
BSAP_	NULL
,	NULL
and	NULL
GAS~	NULL
ECS	NULL
mutant	NULL
constructs	NULL
were	NULL
comparable	NULL
to	NULL
that	NULL
of	NULL
the	NULL
wt	NULL
ECS-SV40-pGL3	NULL
minimal	NULL
promoter	NULL
construct	NULL
,	NULL
which	NULL
was	NULL
significantly	NULL
induced	NULL
by	NULL
either	NULL
htCD40L	NULL
or	NULL
IL-4	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
left	NULL
and	NULL
right	NULL
panels	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
the	NULL
«	NULL
B3	NULL
/kB4~	NULL
ECS	NULL
mutant	NULL
was	NULL
not	NULL
responsive	NULL
to	NULL
htCD40L	NULL
and/or	NULL
IL-4	NULL
,	NULL
whereas	NULL
the	NULL
GAS~	NULL
ECS	NULL
mutant	NULL
lost	NULL
IL-4	NULL
but	NULL
retained	NULL
htCD40L-dependent	NULL
inducibility	NULL
.	NULL

The	NULL
CD40L-mediated	NULL
inducibility	NULL
of	NULL
the	NULL
BSAP_	NULL
ECS	NULL
fragment	NULL
was	NULL
comparable	NULL
to	NULL
that	NULL
of	NULL
the	NULL
wt	NULL
ECS	NULL
construct	NULL
but	NULL
consistently	NULL
showed	NULL
decreased	NULL
IL-4	NULL
responsiveness	NULL
(	NULL
1.5-	NULL
vs	NULL
2.6-fold	NULL
induction	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
while	NULL
the	NULL
wt	NULL
ECS	NULL
fragment	NULL
was	NULL
able	NULL
to	NULL
mediate	NULL
synergistic	NULL
reporter	NULL
activation	NULL
by	NULL
CD4OL	NULL
and	NULL
IL-4	NULL
,	NULL
the	NULL
«	NULL
B3_/kB4~	NULL
or	NULL
GAS~	NULL
ECS	NULL
mutants	NULL
were	NULL
not	NULL
,	NULL
and	NULL
the	NULL
BSAP_	NULL
ECS	NULL
mutant	NULL
displayed	NULL
about	NULL
50	NULL
%	NULL
reduction	NULL
.	NULL

These	NULL
experiments	NULL
demonstrate	NULL
that	NULL
the	NULL
isolated	NULL
ECS	NULL
fragment	NULL
is	NULL
sufficient	NULL
to	NULL
confer	NULL
CD4OL	NULL
and	NULL
IL-4	NULL
inducibility	NULL
to	NULL
a	NULL
heterologous	NULL
promoter	NULL
and	NULL
further	NULL
verify	NULL
the	NULL
cis-element	NULL
composition	NULL
of	NULL
the	NULL
CD40	NULL
and	NULL
IL-4	NULL
REs	NULL
within	NULL
the	NULL
Cy3	NULL
ECS	NULL
.	NULL

NF-	NULL
«	NULL
B/Rel	NULL
and	NULL
STAT-6	NULL
proteins	NULL
are	NULL
induced	NULL
by	NULL
CD40	NULL
and	NULL
IL-4	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
bind	NULL
to	NULL
their	NULL
respective	NULL
REs	NULL
within	NULL
the	NULL
human	NULL
ECS-Iy3	NULL
region	NULL
NF-	NULL
«	NULL
B/Rel	NULL
!	NULL

and	NULL
STAT-6	NULL
transcription	NULL
factors	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
CD40	NULL
and	NULL
IL-4	NULL
REs	NULL
of	NULL
the	NULL
mouse	NULL
Cy1	NULL
and	NULL
Ce	NULL
genes	NULL
(	NULL
17-20	NULL
,	NULL
35	NULL
)	NULL
.	NULL

Appropriate	NULL
EMSAs	NULL
were	NULL
performed	NULL
to	NULL
verify	NULL
whether	NULL
these	NULL
proteins	NULL
can	NULL
be	NULL
induced	NULL
by	NULL
htCD40L	NULL
and/or	NULL
IL-4	NULL
and	NULL
bind	NULL
to	NULL
the	NULL
CD40	NULL
and	NULL
IL-4	NULL
REs	NULL
of	NULL
the	NULL
human	NULL
ECS-Iy3	NULL
region	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
5332	NULL
HUMAN	NULL
ECS-Iy3	NULL
IS	NULL
A	NULL
FUNCTIONAL	NULL
GENE	NULL
PROMOTER	NULL
-449	NULL
-239	NULL
-157	NULL
-65	NULL
+265	NULL
KB	NULL
.	NULL

BSAP	NULL
GAS	NULL
145	NULL
deck	NULL
,	NULL
``	NULL
**	NULL
Luc	NULL
£113\	NULL
wh	NULL
C	NULL
-139	NULL
55	NULL
BSAP	NULL
GAS	NULL
6	NULL
c	NULL
wt	NULL
€	NULL
i	NULL
KB4~	NULL
c	NULL
BSAP®	NULL
o	NULL
ISRE	NULL
«	NULL
B5Y/C-EBP~	NULL
GAS	NULL
:	NULL
KB3	NULL
``	NULL
,	NULL
KB4	NULL
``	NULL
.	NULL

ccreretcrecacaagererceccer	NULL
is	NULL
_____	NULL
Medium	NULL
alone	NULL
_	NULL
y-	NULL
htCD40L	NULL
po	NULL
p	NULL
IL-4	NULL
e	NULL
htCD40L	NULL
+	NULL
IL-4	NULL
Las	NULL
]	NULL
25	NULL
;	NULL
nem	NULL
te	NULL
==	NULL
P	NULL
'	NULL
5	NULL
=	NULL
I	NULL
|	NULL
20|	NULL
i	NULL
.	NULL

f	NULL
‘	NULL
2	NULL
*	NULL
}	NULL
;	NULL
1	NULL
|	NULL
&	NULL
1	NULL
[	NULL
|	NULL
§	NULL
``	NULL
2	NULL
0|	NULL
§	NULL
°	NULL
|	NULL
[	NULL
31	NULL
€*	NULL
]	NULL
§	NULL
``	NULL
)	NULL
§	NULL
W	NULL
;	NULL
I	NULL
‘	NULL
q	NULL
_	NULL
£	NULL
R	NULL
)	NULL
3.	NULL
,	NULL
|	NULL
|	NULL
2	NULL
s	NULL
3	NULL
|f	NULL
;	NULL
R	NULL
|	NULL
E	NULL
J	NULL
|	NULL
$	NULL
|	NULL
£	NULL
_|	NULL
$	NULL
9	NULL
&	NULL
,	NULL
Pil	NULL
/	NULL
q	NULL
A	NULL
9	NULL
|	NULL
a	NULL
:	NULL
|	NULL
<	NULL
£20010	NULL
i	NULL
11	NULL
ON	NULL
+0	NULL
#	NULL
8	NULL
$	NULL
44	NULL
+to	NULL
HH	NULL
&	NULL
LLL	NULL
I1	NULL
[	NULL
|	NULL
LW	NULL
4	NULL
4	NULL
A	NULL
&	NULL
A	NULL
#	NULL
]	NULL
=	NULL
,	NULL
_I	NULL
1	NULL
.	NULL

--	NULL
U	NULL
U	NULL
1	NULL
-	NULL
13	NULL
#	NULL
BB	NULL
(	NULL
MBA	NULL
MND	NULL
MM	NULL
.	NULL

OO	NULL
``	NULL
``	NULL
f	NULL
a	NULL
mio	NULL
wus	NULL
ind	NULL
.	NULL

AHI	NULL
Bear	NULL
GAS	NULL
:	NULL
wh	NULL
o	NULL
kB3~	NULL
«	NULL
B4	NULL
BSAP	NULL
GAS	NULL
who	NULL
kB3~	NULL
«	NULL
B47	NULL
(	NULL
SRES	NULL
«	NULL
B3	NULL
BSAP	NULL
GAS	NULL
[	NULL
crear	NULL
cCeBPr	NULL
cieBp	NULL
FIGURE	NULL
5	NULL
.	NULL

Definition	NULL
of	NULL
the	NULL
CD40	NULL
and	NULL
the	NULL
IL-4	NULL
REs	NULL
within	NULL
the	NULL
human	NULL
ECS-Iy3	NULL
region	NULL
.	NULL

A	NULL
,	NULL
The	NULL
diagram	NULL
depicts	NULL
the	NULL
ECS-Iy3	NULL
region	NULL
with	NULL
the	NULL
putative	NULL
«	NULL
B3	NULL
,	NULL
«	NULL
B4	NULL
,	NULL
ISRE/xB5/C/EBP	NULL
,	NULL
BSAP	NULL
,	NULL
and	NULL
GAS	NULL
sites	NULL
.	NULL

The	NULL
major	NULL
Iy3	NULL
transcriptional	NULL
initiation	NULL
site	NULL
is	NULL
indicated	NULL
by	NULL
a	NULL
turned	NULL
arrow	NULL
.	NULL

Partial	NULL
DNA	NULL
sequences	NULL
of	NULL
(	NULL
-449/+265	NULL
)	NULL
ECS-Iy3	NULL
constructs	NULL
containing	NULL
wt	NULL
or	NULL
mutant	NULL
«	NULL
B3	NULL
,	NULL
«	NULL
B4	NULL
,	NULL
ISRE/kB5/C/EBP	NULL
,	NULL
BSAP	NULL
,	NULL
and	NULL
GAS	NULL
sites	NULL
(	NULL
boxed	NULL
)	NULL
.	NULL

Replacement	NULL
mutations	NULL
are	NULL
indicated	NULL
by	NULL
lower	NULL
case	NULL
italic	NULL
letters	NULL
and	NULL
correspond	NULL
to	NULL
Sacl	NULL
restriction	NULL
sites	NULL
.	NULL

B	NULL
,	NULL
The	NULL
wt	NULL
or	NULL
mutant	NULL
(	NULL
«	NULL
B3	NULL
,	NULL
«	NULL
B4	NULL
,	NULL
ISRE	NULL
/kB5	NULL
/C/EBP_	NULL
,	NULL
kB3~	NULL
«	NULL
B4	NULL
,	NULL
BSAP_~	NULL
,	NULL
and	NULL
GAS	NULL
)	NULL
ECS-Iy3	NULL
region	NULL
constructs	NULL
were	NULL
electroporated	NULL
into	NULL
CL-O1	NULL
cells	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
medium	NULL
only	NULL
,	NULL
or	NULL
in	NULL
medium	NULL
containing	NULL
htCD40L	NULL
,	NULL
IL-4	NULL
,	NULL
or	NULL
both	NULL
htCD40L	NULL
and	NULL
IL-4	NULL
,	NULL
and	NULL
the	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
after	NULL
24	NULL
h.	NULL
Results	NULL
are	NULL
expressed	NULL
as	NULL
relative	NULL
light	NULL
units	NULL
(	NULL
left	NULL
panel	NULL
)	NULL
and	NULL
fold	NULL
induction	NULL
(	NULL
right	NULL
three	NULL
panels	NULL
)	NULL
.	NULL

Results	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
three	NULL
independent	NULL
transfection	NULL
experiments	NULL
.	NULL

CL-O1	NULL
cells	NULL
and	NULL
naive	NULL
B	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
medium	NULL
only	NULL
or	NULL
amide	NULL
gel	NULL
.	NULL

Nuclear	NULL
proteins	NULL
from	NULL
unstimulated	NULL
CL-O01	NULL
cells	NULL
showed	NULL
in	NULL
medium	NULL
containing	NULL
htCD40L	NULL
,	NULL
IL-4	NULL
,	NULL
or	NULL
both	NULL
.	NULL

After	NULL
12	NULL
h	NULL
,	NULL
the	NULL
a	NULL
weak	NULL
«	NULL
kB3-binding	NULL
activity	NULL
as	NULL
revealed	NULL
by	NULL
three	NULL
shifted	NULL
bands	NULL
nuclear	NULL
proteins	NULL
were	NULL
extracted	NULL
and	NULL
incubated	NULL
with	NULL
radiolabeled	NULL
with	NULL
slower	NULL
(	NULL
complexes	NULL
A	NULL
and	NULL
B	NULL
)	NULL
and	NULL
faster	NULL
(	NULL
complex	NULL
C	NULL
)	NULL
mobility	NULL
«	NULL
B3	NULL
or	NULL
GAS	NULL
probes	NULL
before	NULL
fractionation	NULL
through	NULL
a	NULL
6	NULL
%	NULL
polyacryl-	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
B	NULL
cells	NULL
by	NULL
htCD4OL	NULL
,	NULL
but	NULL
not	NULL
IL-4	NULL
,	NULL
[	NULL
J	NULL
medium	NULL
alone	NULL
7	NULL
htCD40L	NULL
8	NULL
IL-4	NULL
E	NULL
htCD40L	NULL
+	NULL
IL-4	NULL
+1	NULL
|	NULL
control	NULL
|	NULL
xB	NULL
BSAP	NULL
GAS	NULL
34	NULL
5	NULL
‘	NULL
wt	NULL
ECS	NULL
{	NULL
}	NULL
mss	NULL
r	NULL
(	NULL
F-	NULL
[	NULL
SV40	NULL
p	NULL
}	NULL
Loc	NULL
|	NULL
ECS	NULL
Exif	NULL
fmm	NULL
asl	NULL
to	NULL
Luc	NULL
BSAP-	NULL
ECS	NULL
cf	NULL
|	NULL
}	NULL
Tuc	NULL
GAS	NULL
ECS	NULL
-|	NULL
}	NULL
pay	NULL
fifo	NULL
Luc	NULL
f	NULL
,	NULL
‘	NULL
Eos	NULL
239	NULL
65	NULL
0	NULL
1500	NULL
3000	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
Relative	NULL
light	NULL
units	NULL
Fold	NULL
induction	NULL
FIGURE	NULL
6	NULL
.	NULL

-	NULL
Inducibility	NULL
of	NULL
the	NULL
human	NULL
Cy3	NULL
ECS	NULL
segment	NULL
by	NULL
CD4OL	NULL
and/or	NULL
IL-4	NULL
using	NULL
a	NULL
heterologous	NULL
minimal	NULL
promoter	NULL
construct	NULL
.	NULL

Wild-type	NULL
or	NULL
mutant	NULL
«	NULL
B3~	NULL
«	NULL
kB4~	NULL
,	NULL
BSAP_	NULL
,	NULL
or	NULL
GAS~	NULL
ECS	NULL
fragments	NULL
(	NULL
extending	NULL
from	NULL
relative	NULL
position	NULL
-239	NULL
to	NULL
-65	NULL
)	NULL
were	NULL
cloned	NULL
into	NULL
a	NULL
pGL-3	NULL
vector	NULL
containing	NULL
a	NULL
SV40	NULL
minimal	NULL
promoter	NULL
.	NULL

Transfected	NULL
CL-01	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
medium	NULL
only	NULL
,	NULL
or	NULL
in	NULL
medium	NULL
containing	NULL
htCD40L	NULL
,	NULL
IL-4	NULL
,	NULL
or	NULL
both	NULL
htCD40L	NULL
and	NULL
IL-4	NULL
,	NULL
and	NULL
the	NULL
luciferase	NULL
gene	NULL
activity	NULL
was	NULL
measured	NULL
after	NULL
24	NULL
h.	NULL
Readings	NULL
are	NULL
expressed	NULL
as	NULL
relative	NULL
light	NULL
units	NULL
(	NULL
eft	NULL
panel	NULL
)	NULL
and	NULL
fold	NULL
induction	NULL
(	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

Results	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
three	NULL
independent	NULL
transfection	NULL
experiments	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
£	NULL
8	NULL
G.	NULL
htCDAOL	NULL
|	NULL
g	NULL
-	NULL
+0	NULL
-	NULL
+00	NULL
-	NULL
£0	NULL
-	NULL
+	NULL
IL-4	NULL
s	NULL
%	NULL
=	NULL
+	NULL
+	NULL
«	NULL
=	NULL
+o	NULL
+	NULL
l	NULL
¥	NULL
@	NULL
#	NULL
#	NULL
-~	NULL
»	NULL
-	NULL
#	NULL
1	NULL
-	NULL
_2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
17	NULL
8	NULL
9	NULL
5333	NULL
<	NULL
m	NULL
2	NULL
het	NULL
3	NULL
m	NULL
s	NULL
2	NULL
g	NULL
5	NULL
bog	NULL
#	NULL
g	NULL
2	NULL
3	NULL
5	NULL
m	NULL
S	NULL
so	NULL
mA	NULL
mR	NULL
Ao	NULL
s	NULL
M	NULL
8	NULL
&	NULL
®	NULL
f	NULL
8	NULL
s	NULL
s	NULL
s	NULL
s	NULL
s	NULL
Complex	NULL
A	NULL
50/p65	NULL
)	NULL
tole	NULL
<	NULL
4	NULL
(	NULL
P	NULL
u	NULL
H	NULL
b	NULL
4	NULL
.	NULL

``	NULL
.	NULL

t	NULL
im	NULL
Complex	NULL
B	NULL
(	NULL
p50/c-Rel	NULL
)	NULL
Complex	NULL
C	NULL
(	NULL
pS0/p50	NULL
)	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
18	NULL
19	NULL
CL-O01	NULL
cells	NULL
Naive	NULL
tonsillar	NULL
B	NULL
cells	NULL
6:1	NULL
:	NULL
(	NULL
é	NULL
é	NULL
,	NULL
on	NULL
un	NULL
o	NULL
burt	NULL
um	NULL
G	NULL
1	NULL
+	NULL
|	NULL
m	NULL
3	NULL
&	NULL
e	NULL
0	NULL
E	NULL
=	NULL
&	NULL
&	NULL
htCD40L	NULL
§	NULL
-	NULL
#	NULL
0	NULL
-	NULL
#	NULL
o-	NULL
#	NULL
-	NULL
%	NULL
§	NULL
2	NULL
38	NULL
S	NULL
§	NULL
£	NULL
g	NULL
g	NULL
IL-4	NULL
ho	NULL
.	NULL

o.	NULL
goos	NULL
o-	NULL
$	NULL
o	NULL
3	NULL
aos	NULL
oE	NULL
3	NULL
s	NULL
so	NULL
8	NULL
®	NULL
(	NULL
!	NULL

-a	NULL
stats	NULL
supershift	NULL
+	NULL
tinal	NULL
tt	NULL
Gal	NULL
-	NULL
tat	NULL
kot	NULL
-	NULL
oA	NULL
bok	NULL
4	NULL
«	NULL
%	NULL
STAT-6	NULL
Io	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
CL-01	NULL
cells	NULL
Naive	NULL
tonsillar	NULL
B	NULL
cells	NULL
FIGURE	NULL
7	NULL
.	NULL

-	NULL
EMSA	NULL
analysis	NULL
of	NULL
nucleoprotein	NULL
complexes	NULL
binding	NULL
to	NULL
the	NULL
«	NULL
B3	NULL
and	NULL
GAS	NULL
sites	NULL
of	NULL
the	NULL
CD40	NULL
and	NULL
IL-4	NULL
REs	NULL
within	NULL
the	NULL
ECS	NULL
.	NULL

CL-O1	NULL
and	NULL
normal	NULL
naive	NULL
B	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
medium	NULL
only	NULL
,	NULL
or	NULL
in	NULL
medium	NULL
containing	NULL
htCD40L	NULL
,	NULL
IL-4	NULL
,	NULL
or	NULL
both	NULL
htCD40L	NULL
and	NULL
IL-4	NULL
for	NULL
12	NULL
h.	NULL
Nuclear	NULL
extracts	NULL
were	NULL
first	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
with	NULL
radiolabeled	NULL
oligonucleotides	NULL
encompassing	NULL
the	NULL
ECS	NULL
«	NULL
B3	NULL
site	NULL
(	NULL
A	NULL
)	NULL
or	NULL
the	NULL
GAS	NULL
site	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
subsequently	NULL
fractionated	NULL
into	NULL
a	NULL
6	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
9	NULL
;	NULL
lane	NULL
1	NULL
contains	NULL
the	NULL
protein-free	NULL
probe	NULL
)	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
shifted	NULL
bands	NULL
and	NULL
their	NULL
identity	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
complexes	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
)	NULL
or	NULL
STAT-6	NULL
were	NULL
established	NULL
by	NULL
preincubating	NULL
nuclear	NULL
proteins	NULL
with	NULL
competitors	NULL
,	NULL
as	NULL
detailed	NULL
in	NULL
the	NULL
text	NULL
(	NULL
Janes	NULL
11	NULL
to	NULL
13	NULL
)	NULL
.	NULL

The	NULL
immunoreactivity	NULL
of	NULL
the	NULL
shifted	NULL
bands	NULL
was	NULL
determined	NULL
by	NULL
preincubating	NULL
nuclear	NULL
proteins	NULL
with	NULL
blocking	NULL
Abs	NULL
to	NULL
human	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
p65	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
Rel	NULL
B	NULL
proteins	NULL
(	NULL
A	NULL
,	NULL
lanes	NULL
15	NULL
to	NULL
19	NULL
)	NULL
,	NULL
or	NULL
with	NULL
supershifting	NULL
Abs	NULL
to	NULL
human	NULL
STAT-3	NULL
,	NULL
STAT-5	NULL
,	NULL
and	NULL
STAT-6	NULL
proteins	NULL
(	NULL
B	NULL
,	NULL
lanes	NULL
15	NULL
to	NULL
17	NULL
)	NULL
.	NULL

An	NULL
Ab	NULL
to	NULL
human	NULL
thyroglobulin	NULL
was	NULL
used	NULL
as	NULL
control	NULL
(	NULL
A	NULL
and	NULL
B	NULL
,	NULL
lanes	NULL
14	NULL
)	NULL
.	NULL

greatly	NULL
increased	NULL
the	NULL
intensity	NULL
of	NULL
complexes	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
IL-4	NULL
to	NULL
htCD4O0L	NULL
further	NULL
enhanced	NULL
the	NULL
htCD40L-induced	NULL
«	NULL
B3-binding	NULL
activity	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
naive	NULL
B	NULL
cells	NULL
cultured	NULL
under	NULL
the	NULL
above	NULL
conditions	NULL
displayed	NULL
similar	NULL
«	NULL
B3-binding	NULL
and	NULL
induction	NULL
patterns	NULL
,	NULL
with	NULL
a	NULL
somewhat	NULL
more	NULL
pronounced	NULL
formation	NULL
of	NULL
complex	NULL
C	NULL
following	NULL
htCD4O0L	NULL
and	NULL
IL-4	NULL
stimulation	NULL
(	NULL
Zanes	NULL
6-9	NULL
)	NULL
.	NULL

The	NULL
htCD4O0L-induced	NULL
binding	NULL
to	NULL
the	NULL
radiolabeled	NULL
B3	NULL
probe	NULL
was	NULL
specific	NULL
,	NULL
as	NULL
it	NULL
was	NULL
inhibited	NULL
by	NULL
a	NULL
``	NULL
cold	NULL
``	NULL
wt	NULL
«	NULL
B3	NULL
oligonucleotide	NULL
(	NULL
lanes	NULL
10	NULL
and	NULL
17	NULL
)	NULL
.	NULL

It	NULL
was	NULL
also	NULL
inhibited	NULL
by	NULL
a	NULL
wt	NULL
consensus	NULL
NF-KB	NULL
binding	NULL
site	NULL
from	NULL
the	NULL
Ig	NULL
x	NULL
promoter	NULL
(	NULL
lane	NULL
12	NULL
)	NULL
,	NULL
but	NULL
not	NULL
by	NULL
a	NULL
mutated	NULL
form	NULL
of	NULL
the	NULL
latter	NULL
(	NULL
lane	NULL
13	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
complexes	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
contain	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

proteins	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
composition	NULL
of	NULL
these	NULL
complexes	NULL
,	NULL
htCD40L-induced	NULL
nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
Abs	NULL
to	NULL
human	NULL
thyroglobulin	NULL
(	NULL
control	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
human	NULL
p65	NULL
,	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
Rel	NULL
B	NULL
proteins	NULL
.	NULL

Complex	NULL
A	NULL
was	NULL
inhibited	NULL
by	NULL
Abs	NULL
to	NULL
p50	NULL
and	NULL
p65	NULL
;	NULL
complex	NULL
B	NULL
by	NULL
Abs	NULL
to	NULL
p50	NULL
and	NULL
c-Rel	NULL
;	NULL
and	NULL
complex	NULL
C	NULL
only	NULL
by	NULL
Ab	NULL
to	NULL
p50	NULL
;	NULL
none	NULL
of	NULL
the	NULL
complexes	NULL
were	NULL
inhibited	NULL
by	NULL
the	NULL
control	NULL
Ab	NULL
or	NULL
by	NULL
Abs	NULL
to	NULL
p52	NULL
or	NULL
Rel	NULL
B	NULL
(	NULL
Zanes	NULL
14-19	NULL
)	NULL
.	NULL

When	NULL
the	NULL
«	NULL
B4	NULL
sequence	NULL
was	NULL
utilized	NULL
as	NULL
a	NULL
probe	NULL
,	NULL
DNA	NULL
binding	NULL
complexes	NULL
with	NULL
similar	NULL
elec-	NULL
trophoretic	NULL
mobility	NULL
were	NULL
detected	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
CD40	NULL
engagement	NULL
induces	NULL
the	NULL
binding	NULL
of	NULL
p50/p65	NULL
,	NULL
p50/c-Rel	NULL
,	NULL
and	NULL
p50/	NULL
p50	NULL
NF-	NULL
«	NULL
B/Rel	NULL
complexes	NULL
to	NULL
the	NULL
CD40	NULL
RE	NULL
of	NULL
the	NULL
human	NULL
ECS-Iy3	NULL
region	NULL
.	NULL

The	NULL
CD4O0-dependent	NULL
induction	NULL
of	NULL
these	NULL
complexes	NULL
and	NULL
their	NULL
specific	NULL
DNA	NULL
binding	NULL
are	NULL
enhanced	NULL
by	NULL
IL-4	NULL
.	NULL

Nuclear	NULL
proteins	NULL
from	NULL
unstimulated	NULL
or	NULL
htCD4O0L-induced	NULL
CL-O1	NULL
cells	NULL
did	NULL
not	NULL
show	NULL
any	NULL
specific	NULL
binding	NULL
to	NULL
the	NULL
GAS	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

78	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
;	NULL
incubation	NULL
of	NULL
CL-O1	NULL
cells	NULL
with	NULL
IL-4	NULL
induced	NULL
a	NULL
slowly	NULL
migrating	NULL
band	NULL
that	NULL
was	NULL
slightly	NULL
enhanced	NULL
by	NULL
costimulation	NULL
with	NULL
htCD40L	NULL
(	NULL
Zanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Similar	NULL
DNA	NULL
binding	NULL
patterns	NULL
were	NULL
reproduced	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
freshly	NULL
isolated	NULL
B	NULL
cells	NULL
in	NULL
identical	NULL
experimental	NULL
conditions	NULL
(	NULL
Zanes	NULL
6	NULL
to	NULL
9	NULL
)	NULL
.	NULL

The	NULL
IL-4-induced	NULL
DNA-protein	NULL
complex	NULL
was	NULL
specific	NULL
,	NULL
as	NULL
it	NULL
was	NULL
cleared	NULL
by	NULL
a	NULL
nonla-beled	NULL
I1y3	NULL
GAS	NULL
oligo	NULL
(	NULL
lane	NULL
11	NULL
)	NULL
.	NULL

A	NULL
wt	NULL
STAT-6-binding	NULL
oligonu-cleotide	NULL
,	NULL
but	NULL
not	NULL
a	NULL
nonfunctional	NULL
mutant	NULL
derived	NULL
from	NULL
the	NULL
human	NULL
Ce	NULL
promoter	NULL
,	NULL
inhibited	NULL
the	NULL
IL-4-induced	NULL
band	NULL
shift	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
IL-4-induced	NULL
complex	NULL
contained	NULL
STAT-6	NULL
(	NULL
Zanes	NULL
12	NULL
and	NULL
13	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
preincubation	NULL
of	NULL
IL-4-induced	NULL
nuclear	NULL
proteins	NULL
with	NULL
Abs	NULL
to	NULL
human	NULL
STAT-6	NULL
,	NULL
but	NULL
not	NULL
thyroglobulin	NULL
,	NULL
STAT-3	NULL
,	NULL
and	NULL
STAT-5	NULL
proteins	NULL
supershifted	NULL
the	NULL
IL-4-induced	NULL
complex	NULL
(	NULL
lanes	NULL
14	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
5334	NULL
to	NULL
17	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
IL-4	NULL
induces	NULL
STAT-6	NULL
binding	NULL
to	NULL
the	NULL
GAS	NULL
site	NULL
of	NULL
the	NULL
IL-4	NULL
RE	NULL
of	NULL
the	NULL
human	NULL
Cy3	NULL
ECS	NULL
,	NULL
and	NULL
this	NULL
binding	NULL
is	NULL
enhanced	NULL
by	NULL
CD40	NULL
coengagement	NULL
.	NULL

Discussion	NULL
These	NULL
studies	NULL
show	NULL
that	NULL
the	NULL
ECS	NULL
upstream	NULL
of	NULL
the	NULL
human	NULL
Sy3	NULL
region	NULL
is	NULL
a	NULL
promoter	NULL
that	NULL
is	NULL
synergistically	NULL
activated	NULL
by	NULL
CD4O0L	NULL
and	NULL
IL-4	NULL
through	NULL
the	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

l	NULL
and	NULL
STAT-6	NULL
proteins	NULL
.	NULL

They	NULL
show	NULL
that	NULL
two	NULL
tandem	NULL
«	NULL
B	NULL
elements	NULL
within	NULL
the	NULL
ECS	NULL
are	NULL
critical	NULL
for	NULL
the	NULL
CD40-dependent	NULL
promoter	NULL
activation	NULL
as	NULL
they	NULL
constitute	NULL
the	NULL
target	NULL
of	NULL
CD4OL-induced	NULL
NE-	NULL
«	NULL
B/Rel	NULL
transcription	NULL
factors	NULL
(	NULL
CD40	NULL
RE	NULL
)	NULL
.	NULL

They	NULL
define	NULL
a	NULL
canonical	NULL
GAS	NULL
site	NULL
that	NULL
,	NULL
together	NULL
with	NULL
the	NULL
CD4ORE	NULL
,	NULL
confers	NULL
IL-4-dependent	NULL
inducibility	NULL
to	NULL
the	NULL
ECS	NULL
,	NULL
as	NULL
it	NULL
provides	NULL
a	NULL
specific	NULL
target	NULL
for	NULL
the	NULL
IL-4-induced	NULL
STAT-6	NULL
(	NULL
IL-4	NULL
RE	NULL
)	NULL
.	NULL

They	NULL
demonstrate	NULL
a	NULL
BSAP	NULL
binding	NULL
site	NULL
residing	NULL
between	NULL
the	NULL
«	NULL
B	NULL
and	NULL
GAS	NULL
elements	NULL
to	NULL
be	NULL
important	NULL
for	NULL
IL-4	NULL
,	NULL
but	NULL
not	NULL
for	NULL
CD4O0L-dependent	NULL
inducibility	NULL
.	NULL

Finally	NULL
,	NULL
they	NULL
indicate	NULL
that	NULL
the	NULL
partially	NULL
overlapping	NULL
organization	NULL
of	NULL
these	NULL
CD40	NULL
and	NULL
IL-4	NULL
REs	NULL
is	NULL
a	NULL
critical	NULL
structural	NULL
feature	NULL
for	NULL
the	NULL
synergistic	NULL
promoter	NULL
activation	NULL
by	NULL
enabling	NULL
functional	NULL
cooperation	NULL
between	NULL
NF-	NULL
«	NULL
B/Rel	NULL
,	NULL
BSAP	NULL
,	NULL
and	NULL
STAT-6	NULL
binding	NULL
sites	NULL
.	NULL

In	NULL
murine	NULL
B	NULL
cells	NULL
,	NULL
CD40	NULL
engagement	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
additional	NULL
stimuli	NULL
,	NULL
induces	NULL
germline	NULL
[	NULL
y1-Cy1	NULL
and	NULL
Ie-Ce	NULL
gene	NULL
transcription	NULL
through	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
corresponding	NULL
promoters	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

This	NULL
transcriptional	NULL
inducibility	NULL
is	NULL
dependent	NULL
on	NULL
distinct	NULL
CD40	NULL
REs	NULL
composed	NULL
of	NULL
tandemly	NULL
arrayed	NULL
NF-KB	NULL
binding	NULL
sites	NULL
.	NULL

Like-wise	NULL
,	NULL
human	NULL
B	NULL
cells	NULL
stimulated	NULL
through	NULL
CD40	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
express	NULL
multiple	NULL
I	NULL
;	NULL
,	NULL
-C	NULL
,	NULL
,	NULL
germline	NULL
transcripts	NULL
,	NULL
including	NULL
1y3-Cy3	NULL
(	NULL
13	NULL
,	NULL
14	NULL
,	NULL
37	NULL
,	NULL
38	NULL
)	NULL
,	NULL
but	NULL
€CD40-induced	NULL
activation	NULL
of	NULL
the	NULL
corresponding	NULL
C	NULL
,	NULL
,	NULL
gene	NULL
promoters	NULL
has	NULL
not	NULL
been	NULL
formally	NULL
demonstrated	NULL
,	NULL
and	NULL
the	NULL
related	NULL
CD40	NULL
REs	NULL
have	NULL
not	NULL
been	NULL
defined	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
show	NULL
that	NULL
the	NULL
CD40-dependent	NULL
induction	NULL
of	NULL
germline	NULL
I1y3-Cy3	NULL
transcription	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
ECS-Iy3	NULL
promoter	NULL
region	NULL
via	NULL
two	NULL
tandem	NULL
B	NULL
sites	NULL
(	NULL
B3	NULL
and	NULL
B4	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
these	NULL
NF-KB	NULL
binding	NULL
sites	NULL
and	NULL
the	NULL
intervening	NULL
DNA	NULL
are	NULL
identical	NULL
in	NULL
all	NULL
human	NULL
Cy	NULL
ECS	NULL
regions	NULL
(	NULL
6	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
CD40	NULL
signaling	NULL
is	NULL
critical	NULL
not	NULL
only	NULL
for	NULL
1y3-Cy3	NULL
,	NULL
but	NULL
also	NULL
for	NULL
Iy1-Cy1	NULL
,	NULL
1y2-Cy2	NULL
,	NULL
and	NULL
1y4-Cy4	NULL
germline	NULL
transcription	NULL
.	NULL

Our	NULL
experiments	NULL
show	NULL
that	NULL
,	NULL
upon	NULL
CD40	NULL
triggering	NULL
,	NULL
p50/p65	NULL
,	NULL
p50/c-Rel	NULL
,	NULL
and	NULL
p50/p50	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

complexes	NULL
bind	NULL
to	NULL
the	NULL
«	NULL
B3	NULL
site	NULL
of	NULL
the	NULL
Cy3	NULL
CD40	NULL
RE	NULL
.	NULL

This	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
pattern	NULL
is	NULL
reminiscent	NULL
of	NULL
that	NULL
of	NULL
the	NULL
mouse	NULL
Cy1	NULL
CD40	NULL
RE	NULL
,	NULL
which	NULL
binds	NULL
p50/Re	NULL
!	NULL

B	NULL
het-erodimers	NULL
(	NULL
19	NULL
)	NULL
.	NULL

While	NULL
the	NULL
probe	NULL
used	NULL
to	NULL
analyze	NULL
the	NULL
NF-KB	NULL
binding	NULL
pattern	NULL
of	NULL
the	NULL
mouse	NULL
Cy1	NULL
CD40	NULL
RE	NULL
encompassed	NULL
three	NULL
tandem	NULL
xB	NULL
sites	NULL
(	NULL
collinear	NULL
with	NULL
our	NULL
xB3	NULL
,	NULL
«	NULL
B4	NULL
,	NULL
and	NULL
«	NULL
B5	NULL
sites	NULL
)	NULL
,	NULL
our	NULL
probe	NULL
spanned	NULL
only	NULL
the	NULL
functionally	NULL
dominant	NULL
«	NULL
B3	NULL
site	NULL
.	NULL

We	NULL
did	NULL
not	NULL
verify	NULL
whether	NULL
Rel	NULL
B	NULL
binds	NULL
to	NULL
the	NULL
«	NULL
B4	NULL
or	NULL
«	NULL
B5	NULL
sites	NULL
or	NULL
to	NULL
a	NULL
sequence	NULL
spanning	NULL
both	NULL
xB3	NULL
and	NULL
«	NULL
B4	NULL
sites	NULL
,	NULL
but	NULL
a	NULL
recent	NULL
report	NULL
in	NULL
murine	NULL
B	NULL
cells	NULL
made	NULL
genetically	NULL
deficient	NULL
in	NULL
Rel	NULL
B	NULL
suggests	NULL
that	NULL
this	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
member	NULL
is	NULL
not	NULL
critical	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
germline	NULL
Iy3-Cy3	NULL
transcription	NULL
(	NULL
39	NULL
)	NULL
.	NULL

As	NULL
we	NULL
show	NULL
here	NULL
,	NULL
efficient	NULL
activation	NULL
of	NULL
the	NULL
ECS	NULL
by	NULL
CD40	NULL
ligation	NULL
requires	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
two	NULL
tandemly	NULL
arrayed	NULL
«	NULL
B3	NULL
and	NULL
«	NULL
B4	NULL
sites	NULL
.	NULL

Accordingly	NULL
,	NULL
targeted	NULL
disruption	NULL
of	NULL
one	NULL
of	NULL
these	NULL
sites	NULL
partially	NULL
reduces	NULL
the	NULL
ECS	NULL
responsiveness	NULL
to	NULL
CD40	NULL
signaling	NULL
,	NULL
whereas	NULL
disruption	NULL
of	NULL
both	NULL
sites	NULL
results	NULL
in	NULL
the	NULL
complete	NULL
loss	NULL
of	NULL
CD4O0-dependent	NULL
inducibility	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
oligonucleotides	NULL
spanning	NULL
the	NULL
individual	NULL
«	NULL
B3	NULL
or	NULL
«	NULL
B4	NULL
motifs	NULL
possess	NULL
a	NULL
weaker	NULL
NF-	NULL
«	NULL
B/Rel-binding	NULL
affinity	NULL
than	NULL
a	NULL
composite	NULL
oligonucleotide	NULL
encompassing	NULL
both	NULL
the	NULL
«	NULL
B3	NULL
and	NULL
the	NULL
«	NULL
B4	NULL
sites	NULL
(	NULL
our	NULL
unpublished	NULL
observations	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
functional	NULL
cooperation	NULL
between	NULL
the	NULL
«	NULL
B3	NULL
and	NULL
the	NULL
«	NULL
B4	NULL
elements	NULL
reflects	NULL
the	NULL
cooperative	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
proteins	NULL
to	NULL
these	NULL
sites	NULL
.	NULL

HUMAN	NULL
ECS-Iy3	NULL
IS	NULL
A	NULL
FUNCTIONAL	NULL
GENE	NULL
PROMOTER	NULL
We	NULL
speculate	NULL
that	NULL
the	NULL
tandem	NULL
organization	NULL
of	NULL
the	NULL
relatively	NULL
low	NULL
affinity	NULL
«	NULL
B3	NULL
and	NULL
«	NULL
B4	NULL
sites	NULL
enhances	NULL
the	NULL
trans-activational	NULL
potential	NULL
of	NULL
the	NULL
Cy3	NULL
CD40	NULL
RE	NULL
by	NULL
allowing	NULL
dimer	NULL
:	NULL
dimer	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

inter-actions	NULL
.	NULL

Our	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
B3	NULL
and	NULL
«	NULL
B4	NULL
motifs	NULL
also	NULL
possess	NULL
distinct	NULL
regulatory	NULL
functions	NULL
.	NULL

While	NULL
the	NULL
«	NULL
B3	NULL
site	NULL
is	NULL
dominant	NULL
over	NULL
the	NULL
«	NULL
B4	NULL
site	NULL
in	NULL
mediating	NULL
CD4O-triggered	NULL
transcriptional	NULL
activa-tion	NULL
,	NULL
the	NULL
«	NULL
B4	NULL
,	NULL
but	NULL
not	NULL
the	NULL
«	NULL
B3	NULL
site	NULL
,	NULL
seems	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
maintenance	NULL
of	NULL
the	NULL
basal	NULL
promoter	NULL
activity	NULL
.	NULL

These	NULL
functional	NULL
differences	NULL
might	NULL
stem	NULL
from	NULL
the	NULL
different	NULL
NF-	NULL
«	NULL
B/Rel	NULL
composition	NULL
on	NULL
the	NULL
«	NULL
B3	NULL
and	NULL
«	NULL
B4	NULL
motifs	NULL
,	NULL
as	NULL
suggested	NULL
from	NULL
the	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
Ce	NULL
promoter	NULL
(	NULL
29	NULL
)	NULL
,	NULL
in	NULL
which	NULL
two	NULL
closely	NULL
positioned	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
with	NULL
distinct	NULL
NF-	NULL
«	NULL
B/Rel-binding	NULL
properties	NULL
possess	NULL
different	NULL
functions	NULL
.	NULL

While	NULL
a	NULL
p50/Rel	NULL
B-binding	NULL
«	NULL
B	NULL
site	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
basal	NULL
transcriptional	NULL
activity	NULL
,	NULL
the	NULL
adjacent	NULL
p50/	NULL
p65-binding	NULL
B	NULL
site	NULL
was	NULL
indispensable	NULL
for	NULL
the	NULL
IL-4-dependent	NULL
germline	NULL
Ce	NULL
gene	NULL
expression	NULL
.	NULL

We	NULL
have	NULL
not	NULL
examined	NULL
the	NULL
binding	NULL
of	NULL
BSAP	NULL
to	NULL
the	NULL
putative	NULL
ECS-Iy3	NULL
BSAP	NULL
consensus	NULL
site	NULL
,	NULL
but	NULL
disruption	NULL
of	NULL
this	NULL
element	NULL
did	NULL
not	NULL
reduce	NULL
the	NULL
CD40L-dependent	NULL
inducibility	NULL
.	NULL

This	NULL
is	NULL
in	NULL
contrast	NULL
with	NULL
the	NULL
essential	NULL
role	NULL
of	NULL
BSAP	NULL
in	NULL
the	NULL
response	NULL
of	NULL
the	NULL
human	NULL
Ce	NULL
promoter	NULL
to	NULL
CD40	NULL
engagement	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Several	NULL
critical	NULL
experimental	NULL
parameters	NULL
may	NULL
account	NULL
for	NULL
this	NULL
discrepancy	NULL
,	NULL
including	NULL
the	NULL
sequence	NULL
of	NULL
DNA	NULL
fragment	NULL
tested	NULL
in	NULL
reporter	NULL
assays	NULL
,	NULL
the	NULL
transfection	NULL
protocol	NULL
,	NULL
and	NULL
the	NULL
B	NULL
cell	NULL
lines	NULL
used	NULL
for	NULL
transfections	NULL
.	NULL

Exposure	NULL
of	NULL
B	NULL
cells	NULL
to	NULL
IL-4	NULL
activates	NULL
the	NULL
ECS	NULL
promoter	NULL
and	NULL
induces	NULL
germline	NULL
I1y3-Cy3	NULL
transcription	NULL
.	NULL

Targeted	NULL
ECS-Iy3	NULL
deletional	NULL
mutants	NULL
and	NULL
EMSAs	NULL
revealed	NULL
that	NULL
the	NULL
Cy3	NULL
IL-4	NULL
RE	NULL
includes	NULL
two	NULL
critical	NULL
elements	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel-binding	NULL
«	NULL
B3	NULL
and	NULL
«	NULL
B4	NULL
sites	NULL
and	NULL
the	NULL
downstream	NULL
STAT-6-binding	NULL
GAS	NULL
site	NULL
.	NULL

Since	NULL
the	NULL
disruption	NULL
of	NULL
either	NULL
of	NULL
these	NULL
elements	NULL
abolishes	NULL
the	NULL
IL-4	NULL
respon-siveness	NULL
,	NULL
functional	NULL
cooperation	NULL
between	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

l	NULL
and	NULL
STAT-6	NULL
transcription	NULL
factors	NULL
seems	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
IL-4-dependent	NULL
inducibility	NULL
.	NULL

These	NULL
findings	NULL
extend	NULL
previous	NULL
reports	NULL
showing	NULL
that	NULL
STAT-6	NULL
binding	NULL
sites	NULL
within	NULL
the	NULL
mouse	NULL
Cy1	NULL
or	NULL
the	NULL
mouse	NULL
and	NULL
the	NULL
human	NULL
Ce	NULL
promoters	NULL
require	NULL
the	NULL
presence	NULL
of	NULL
contiguous	NULL
NF-	NULL
«	NULL
B/	NULL
Rel	NULL
or	NULL
C/EBP	NULL
binding	NULL
sites	NULL
to	NULL
confer	NULL
IL-4-dependent	NULL
transcriptional	NULL
activation	NULL
(	NULL
17	NULL
,	NULL
28	NULL
,	NULL
29	NULL
,	NULL
40	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
mouse	NULL
Cy1	NULL
promoter	NULL
,	NULL
the	NULL
IL-4-dependent	NULL
inducibility	NULL
of	NULL
the	NULL
human	NULL
Cy3	NULL
promoter	NULL
is	NULL
not	NULL
dependent	NULL
on	NULL
C/EBP	NULL
,	NULL
as	NULL
mutation	NULL
of	NULL
the	NULL
ISRE/kB5/	NULL
C/EBP	NULL
composite	NULL
element	NULL
does	NULL
not	NULL
lead	NULL
to	NULL
the	NULL
reduction	NULL
of	NULL
IL-4	NULL
inducibility	NULL
,	NULL
possibly	NULL
reflecting	NULL
the	NULL
distinct	NULL
organization	NULL
of	NULL
STAT-6	NULL
and	NULL
C/EBP	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
mouse	NULL
Cyl	NULL
and	NULL
in	NULL
the	NULL
human	NULL
Cy3	NULL
gene	NULL
promoter	NULL
.	NULL

We	NULL
speculate	NULL
that	NULL
the	NULL
functional	NULL
cooperation	NULL
between	NULL
GAS	NULL
,	NULL
«	NULL
B3	NULL
,	NULL
and	NULL
«	NULL
B4	NULL
sites	NULL
within	NULL
the	NULL
IL-4	NULL
RE	NULL
of	NULL
the	NULL
Cy3	NULL
promoter	NULL
underlies	NULL
a	NULL
physical	NULL
interaction	NULL
between	NULL
NF-	NULL
«	NULL
B/Rel	NULL
and	NULL
IL-4-induced	NULL
STAT-6	NULL
proteins	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
hypothesis	NULL
is	NULL
the	NULL
demonstration	NULL
that	NULL
NF-	NULL
«	NULL
B/Rel	NULL
and	NULL
STAT	NULL
proteins	NULL
interact	NULL
with	NULL
non-STAT	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
ba-sic-leucin	NULL
zipper	NULL
family	NULL
members	NULL
(	NULL
41-44	NULL
)	NULL
,	NULL
and	NULL
the	NULL
finding	NULL
that	NULL
the	NULL
cytokine-dependent	NULL
activation	NULL
of	NULL
E-selectin	NULL
and	NULL
IFN-B	NULL
gene	NULL
promoters	NULL
may	NULL
require	NULL
the	NULL
interaction	NULL
between	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
activating	NULL
transcription	NULL
factor-2	NULL
or	NULL
STAT	NULL
proteins	NULL
,	NULL
respectively	NULL
(	NULL
44	NULL
,	NULL
45	NULL
)	NULL
.	NULL

Although	NULL
able	NULL
to	NULL
induce	NULL
the	NULL
Cy3	NULL
promoter	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
additional	NULL
stimuli	NULL
,	NULL
IL-4	NULL
activates	NULL
STAT-6	NULL
,	NULL
but	NULL
not	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

It	NULL
is	NULL
conceivable	NULL
that	NULL
,	NULL
upon	NULL
binding	NULL
to	NULL
the	NULL
GAS	NULL
element	NULL
,	NULL
IL-4-induced	NULL
STAT-6	NULL
interacts	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
constitutively	NULL
bound	NULL
to	NULL
the	NULL
«	NULL
B3	NULL
and	NULL
«	NULL
B4	NULL
sites	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

Several	NULL
mechanisms	NULL
can	NULL
account	NULL
for	NULL
the	NULL
€CD40-	NULL
and	NULL
IL-4R-de-pendent	NULL
transcriptional	NULL
synergism	NULL
.	NULL

First	NULL
,	NULL
the	NULL
overlapping	NULL
organization	NULL
of	NULL
the	NULL
CD40	NULL
and	NULL
IL-4	NULL
REs	NULL
within	NULL
the	NULL
Cy3	NULL
promoter	NULL
may	NULL
provide	NULL
the	NULL
structural	NULL
basis	NULL
for	NULL
the	NULL
transcriptional	NULL
cooperation	NULL
between	NULL
CD40-	NULL
and	NULL
IL-4R-induced	NULL
signals	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
the	NULL
synergistic	NULL
activation	NULL
of	NULL
the	NULL
Cy3	NULL
promoter	NULL
might	NULL
result	NULL
from	NULL
the	NULL
physical	NULL
and/or	NULL
functional	NULL
interaction	NULL
between	NULL
CD4OL-induced	NULL
NF-	NULL
«	NULL
B/	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
Rel	NULL
and	NULL
IL-4-induced	NULL
STAT-6	NULL
proteins	NULL
.	NULL

Interestingly	NULL
,	NULL
B	NULL
cell	NULL
receptor	NULL
(	NULL
BCR	NULL
)	NULL
-induced	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

activation	NULL
does	NULL
not	NULL
synergize	NULL
with	NULL
IL-4R	NULL
co-signaling	NULL
(	NULL
our	NULL
unpublished	NULL
data	NULL
)	NULL
,	NULL
implying	NULL
that	NULL
the	NULL
functionality	NULL
of	NULL
NF-/Rel	NULL
complexes	NULL
induced	NULL
by	NULL
CD40	NULL
and	NULL
BCR	NULL
are	NULL
distinct	NULL
.	NULL

It	NULL
is	NULL
also	NULL
conceivable	NULL
that	NULL
other	NULL
CD4O-specific	NULL
,	NULL
but	NULL
not	NULL
BCR-specific	NULL
,	NULL
transcription	NULL
factors	NULL
interacting	NULL
with	NULL
NF-	NULL
«	NULL
B/Rel	NULL
complexes	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
synergistic	NULL
response	NULL
.	NULL

An	NULL
alternative	NULL
but	NULL
not	NULL
mutually	NULL
exclusive	NULL
hypothesis	NULL
is	NULL
that	NULL
a	NULL
DNA	NULL
segment	NULL
within	NULL
the	NULL
ECS-Iy3	NULL
region	NULL
contains	NULL
a	NULL
CD4OL-	NULL
or	NULL
a	NULL
CD4O0L	NULL
and	NULL
IL-4-dependent	NULL
enhancer	NULL
that	NULL
would	NULL
amplify	NULL
the	NULL
transcriptional	NULL
synergism	NULL
brought	NULL
about	NULL
by	NULL
the	NULL
functional	NULL
interplay	NULL
between	NULL
the	NULL
«	NULL
B3	NULL
,	NULL
«	NULL
B4	NULL
,	NULL
and	NULL
GAS	NULL
sites	NULL
.	NULL

Accordingly	NULL
,	NULL
the	NULL
deletion	NULL
of	NULL
the	NULL
-449	NULL
to	NULL
-352	NULL
ECS-Iy3	NULL
region	NULL
results	NULL
in	NULL
about	NULL
50	NULL
%	NULL
reduction	NULL
of	NULL
the	NULL
CD40L-	NULL
and	NULL
IL-4-induced	NULL
synergism	NULL
.	NULL

In	NULL
both	NULL
CL-O1	NULL
and	NULL
naive	NULL
B	NULL
cells	NULL
,	NULL
CD4O0L-induced	NULL
NF-KB	NULL
binding	NULL
to	NULL
the	NULL
Cy3	NULL
CD40	NULL
RE	NULL
is	NULL
strongly	NULL
enhanced	NULL
by	NULL
IL-4	NULL
.	NULL

This	NULL
enhancement	NULL
may	NULL
rely	NULL
on	NULL
the	NULL
ability	NULL
of	NULL
IL-4	NULL
to	NULL
amplify	NULL
the	NULL
recruitment	NULL
of	NULL
TNFR-associated	NULL
signal	NULL
transducers	NULL
,	NULL
including	NULL
TNFR-associated	NULL
factor-2	NULL
(	NULL
TRAF-2	NULL
)	NULL
,	NULL
a	NULL
well-known	NULL
NF-KB	NULL
acti-vator	NULL
,	NULL
to	NULL
the	NULL
CD4O-signaling	NULL
complex	NULL
(	NULL
46	NULL
,	NULL
47	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
IL-4	NULL
might	NULL
increase	NULL
the	NULL
levels	NULL
of	NULL
active	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

by	NULL
enhancing	NULL
the	NULL
CD40-mediated	NULL
degradation	NULL
of	NULL
IBB	NULL
molecules	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
hypothesis	NULL
is	NULL
the	NULL
demonstration	NULL
that	NULL
IFN-y	NULL
enhances	NULL
the	NULL
TNF-	NULL
«	NULL
-induced	NULL
NF-KB	NULL
activation	NULL
by	NULL
amplifying	NULL
the	NULL
TNF-o	NULL
&	NULL
-dependent	NULL
degradation	NULL
of	NULL
IBB	NULL
proteins	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Whether	NULL
the	NULL
IL-4-mediated	NULL
enhancement	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
!	NULL

l	NULL
binding	NULL
to	NULL
the	NULL
Cy3	NULL
CD40	NULL
RE	NULL
is	NULL
due	NULL
directly	NULL
to	NULL
enhanced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
or	NULL
augmented	NULL
degradation	NULL
of	NULL
IkBB	NULL
proteins	NULL
is	NULL
presently	NULL
addressed	NULL
in	NULL
our	NULL
laboratory	NULL
using	NULL
human	NULL
CL-O01	NULL
cells	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
our	NULL
demonstration	NULL
that	NULL
CD4OL	NULL
and	NULL
IL-4	NULL
cooperatively	NULL
induce	NULL
the	NULL
ECS	NULL
and	NULL
activate	NULL
1y3-Cy3	NULL
germline	NULL
transcription	NULL
provides	NULL
a	NULL
mechanistic	NULL
explanation	NULL
for	NULL
the	NULL
documented	NULL
synergism	NULL
between	NULL
CD4O0L	NULL
and	NULL
IL-4-induced	NULL
signals	NULL
in	NULL
effecting	NULL
S-	NULL
Sy3	NULL
DNA	NULL
recombination	NULL
and	NULL
may	NULL
constitute	NULL
a	NULL
paradigm	NULL
for	NULL
the	NULL
structure-function	NULL
analysis	NULL
of	NULL
other	NULL
human	NULL
Cy	NULL
gene	NULL
regulatory	NULL
regions	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Mei-Tsuey	NULL
Hwang	NULL
for	NULL
her	NULL
help	NULL
and	NULL
most	NULL
stimulating	NULL
discussions	NULL
.	NULL

We	NULL
acknowledge	NULL
the	NULL
critical	NULL
advice	NULL
of	NULL
our	NULL
longtime	NULL
collaborator	NULL
Dr.	NULL
Edward	NULL
E.	NULL
Max	NULL
(	NULL
Food	NULL
and	NULL
Drug	NULL
Administration	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
)	NULL
and	NULL
his	NULL
gift	NULL
of	NULL
the	NULL
plasmid	NULL
containing	NULL
the	NULL
HindIMM/BamHI	NULL
subclone	NULL
of	NULL
the	NULL
5	NULL
human	NULL
S73	NULL
region	NULL
.	NULL

We	NULL
thank	NULL
Dr.	NULL
Satwant	NULL
Narula	NULL
(	NULL
Schering-Plough	NULL
)	NULL
for	NULL
providing	NULL
us	NULL
with	NULL
IL-4	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Stavnezer	NULL
,	NULL
J	NULL
.	NULL

1996	NULL
.	NULL

Antibody	NULL
class	NULL
switching	NULL
.	NULL

Adv	NULL
.	NULL

Immunol	NULL
.	NULL

61:79	NULL
.	NULL

2	NULL
.	NULL

Snapper	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
K.	NULL
B.	NULL
Marcu	NULL
,	NULL
and	NULL
P.	NULL
Zelazowski	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
immunoglobulin	NULL
class	NULL
switch	NULL
:	NULL
beyond	NULL
``	NULL
accessibility	NULL
.	NULL
``	NULL

Immunity	NULL
6:217	NULL
.	NULL

3	NULL
.	NULL

Rabbits	NULL
,	NULL
T.	NULL
H.	NULL
,	NULL
A.	NULL
Forster	NULL
,	NULL
W.	NULL
Dunnick	NULL
,	NULL
and	NULL
D.	NULL
L.	NULL
Bentley	NULL
.	NULL

1980	NULL
.	NULL

The	NULL
role	NULL
of	NULL
gene	NULL
deletion	NULL
in	NULL
the	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
switch	NULL
.	NULL

Nature	NULL
283:351	NULL
.	NULL

4	NULL
.	NULL

Matsuoka	NULL
,	NULL
M.	NULL
,	NULL
K.	NULL
Yoshida	NULL
,	NULL
T.	NULL
Maeda	NULL
,	NULL
S.	NULL
Usuda	NULL
,	NULL
and	NULL
H.	NULL
Sakano	NULL
.	NULL

1990	NULL
.	NULL

Switch	NULL
circular	NULL
DNA	NULL
formed	NULL
in	NULL
cytokine-treated	NULL
mouse	NULL
splenocytes	NULL
:	NULL
evidence	NULL
for	NULL
in-tramolecular	NULL
DNA	NULL
deletion	NULL
in	NULL
immunoglobulin	NULL
class	NULL
switching	NULL
.	NULL

Cell	NULL
62:135	NULL
.	NULL

5	NULL
.	NULL

Schwedler	NULL
,	NULL
V.	NULL
U.	NULL
,	NULL
H.	NULL
M.	NULL
Jack	NULL
,	NULL
and	NULL
M.	NULL
Wabl	NULL
.	NULL

1990	NULL
.	NULL

Circular	NULL
DNA	NULL
is	NULL
a	NULL
product	NULL
of	NULL
the	NULL
immunoglobulin	NULL
class	NULL
switch	NULL
rearrangement	NULL
.	NULL

Nature	NULL
345:452	NULL
.	NULL

6	NULL
.	NULL

Mills	NULL
,	NULL
F.	NULL
C.	NULL
,	NULL
M.	NULL
P.	NULL
Mitchell	NULL
,	NULL
N.	NULL
Harindranath	NULL
,	NULL
and	NULL
E.	NULL
E.	NULL
Max	NULL
.	NULL

1995	NULL
.	NULL

Human	NULL
Ig	NULL
Sy	NULL
regions	NULL
and	NULL
their	NULL
participation	NULL
in	NULL
sequential	NULL
switching	NULL
to	NULL
IgE	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

155	NULL
;	NULL
3021	NULL
.	NULL

7	NULL
.	NULL

Lutzker	NULL
,	NULL
S.	NULL
,	NULL
P.	NULL
Rothman	NULL
,	NULL
R.	NULL
Pollock	NULL
,	NULL
R.	NULL
Coffman	NULL
,	NULL
and	NULL
F.	NULL
W.	NULL
Alt	NULL
.	NULL

1988	NULL
.	NULL

Mitogen-and	NULL
IL-4-regulated	NULL
expression	NULL
of	NULL
germ-line	NULL
Ig	NULL
y2b	NULL
transcripts	NULL
:	NULL
evidence	NULL
for	NULL
directed	NULL
heavy	NULL
chain	NULL
class	NULL
switching	NULL
.	NULL

Cell	NULL
53:177	NULL
.	NULL

8	NULL
.	NULL

Lutzker	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
F.	NULL
W.	NULL
Alt	NULL
.	NULL

1988	NULL
.	NULL

Structure	NULL
and	NULL
expression	NULL
of	NULL
germ	NULL
line	NULL
immunoglobulin	NULL
y2b	NULL
transcripts	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:1849	NULL
.	NULL

9	NULL
.	NULL

Sideras	NULL
,	NULL
P.	NULL
,	NULL
T.	NULL
R.	NULL
Mizuta	NULL
,	NULL
H.	NULL
Kanamori	NULL
,	NULL
N.	NULL
Suzuki	NULL
,	NULL
M.	NULL
Okamoto	NULL
,	NULL
K.	NULL
Kuze	NULL
,	NULL
H.	NULL
Ohno	NULL
,	NULL
S.	NULL
Doi	NULL
,	NULL
S.	NULL
Fukubara	NULL
,	NULL
M.	NULL
S.	NULL
Hassan	NULL
,	NULL
L.	NULL
Hammarstrom	NULL
,	NULL
E.	NULL
Smith	NULL
,	NULL
A.	NULL
Shimizu	NULL
,	NULL
and	NULL
T.	NULL
Honjo	NULL
.	NULL

1989	NULL
.	NULL

Production	NULL
of	NULL
sterile	NULL
transcripts	NULL
of	NULL
Cy	NULL
genes	NULL
in	NULL
an	NULL
IgM-producing	NULL
human	NULL
neoplastic	NULL
B	NULL
cell	NULL
line	NULL
that	NULL
switches	NULL
to	NULL
IgG-producing	NULL
cells	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

1:631	NULL
.	NULL

10	NULL
.	NULL

Rothman	NULL
,	NULL
P.	NULL
,	NULL
Y.	NULL
Y	NULL
Chen	NULL
,	NULL
S.	NULL
Luizker	NULL
,	NULL
S.	NULL
C.	NULL
Li	NULL
,	NULL
V.	NULL
Stewart	NULL
,	NULL
R.	NULL
Coffman	NULL
,	NULL
and	NULL
F.	NULL
W.	NULL
Alt	NULL
.	NULL

1990	NULL
.	NULL

Structure	NULL
and	NULL
expression	NULL
of	NULL
germ	NULL
line	NULL
immunoglobulin	NULL
heavy	NULL
11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

5335	NULL
chain	NULL
e	NULL
transcripts	NULL
:	NULL
interleukin-4	NULL
plus	NULL
lipopolysaccharide-directed	NULL
switching	NULL
to	NULL
Ce	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:1672	NULL
.	NULL

Gerondakis	NULL
,	NULL
S.	NULL
1990	NULL
.	NULL

Structure	NULL
and	NULL
expression	NULL
of	NULL
murine	NULL
germ-line	NULL
immunoglobulin	NULL
e	NULL
heavy	NULL
chain	NULL
transcripts	NULL
induced	NULL
by	NULL
interleukin	NULL
4	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:1581	NULL
.	NULL

Lorenz	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
Jung	NULL
,	NULL
and	NULL
A.	NULL
Radbruch	NULL
.	NULL

1995	NULL
.	NULL

Switch	NULL
transcripts	NULL
in	NULL
immunoglobulin	NULL
class	NULL
switching	NULL
.	NULL

Science	NULL
267:1825	NULL
.	NULL

Cerutti	NULL
,	NULL
A.	NULL
,	NULL
H.	NULL
Zan	NULL
,	NULL
A.	NULL
Schaffer	NULL
,	NULL
L.	NULL
Bergsagel	NULL
,	NULL
N.	NULL
Harindranath	NULL
,	NULL
E.	NULL
E.	NULL
Max	NULL
,	NULL
and	NULL
P.	NULL
Casali	NULL
.	NULL

1998	NULL
.	NULL

CD40	NULL
ligand	NULL
and	NULL
appropriate	NULL
cytokines	NULL
induce	NULL
switching	NULL
to	NULL
IgG	NULL
,	NULL
IgA	NULL
,	NULL
and	NULL
IgE	NULL
and	NULL
coordinated	NULL
germinal	NULL
center	NULL
and	NULL
plasmacytoid	NULL
phenotypic	NULL
differentiation	NULL
in	NULL
a	NULL
human	NULL
monoclonal	NULL
Ig	NULL
M*	NULL
IgD*	NULL
B	NULL
cell	NULL
line	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160	NULL
:	NULL
2145	NULL
.	NULL

Cerutti	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Schaffer	NULL
,	NULL
S.	NULL
Shah	NULL
,	NULL
H.	NULL
Zan	NULL
,	NULL
H.-C.	NULL
Liou	NULL
,	NULL
R.	NULL
G.	NULL
Goodwin	NULL
,	NULL
and	NULL
P.	NULL
Casali	NULL
.	NULL

1998	NULL
.	NULL

CD30	NULL
is	NULL
a	NULL
CD40-inducible	NULL
molecule	NULL
that	NULL
negatively	NULL
regulates	NULL
CD4O-mediated	NULL
immunoglobulin	NULL
class	NULL
switching	NULL
in	NULL
non	NULL
antigen-selected	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

Immunity	NULL
9:247	NULL
.	NULL

Zan	NULL
,	NULL
H.	NULL
,	NULL
A.	NULL
Cerutti	NULL
,	NULL
P.	NULL
Dramitinos	NULL
,	NULL
A.	NULL
Schaffer	NULL
,	NULL
and	NULL
P.	NULL
Casali	NULL
.	NULL

1998	NULL
.	NULL

CD40	NULL
engagement	NULL
triggers	NULL
switching	NULL
to	NULL
IgA1	NULL
and	NULL
IgA2	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
through	NULL
induction	NULL
of	NULL
endogenous	NULL
TGF-	NULL
$	NULL
1	NULL
:	NULL
evidence	NULL
for	NULL
TGE-	NULL
$	NULL
but	NULL
not	NULL
IL-10-dependent	NULL
direct	NULL
Su-Sa	NULL
and	NULL
sequential	NULL
Su-Sy	NULL
,	NULL
Sy-Sa	NULL
DNA	NULL
recombination	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:5217	NULL
.	NULL

DiSanto	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
J.	NULL
Y.	NULL
Bonnefoy	NULL
,	NULL
J.	NULL
F.	NULL
Gauchat	NULL
,	NULL
A.	NULL
Fischer	NULL
,	NULL
and	NULL
G.	NULL
d.	NULL
S.	NULL
Basile	NULL
.	NULL

1993	NULL
.	NULL

CD40	NULL
ligand	NULL
mutations	NULL
in	NULL
X-linked	NULL
immunodeficiency	NULL
with	NULL
hyper-IgM	NULL
.	NULL

Nature	NULL
361:541	NULL
.	NULL

Delphin	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
J.	NULL
Stavnezer	NULL
.	NULL

1995	NULL
.	NULL

Characterization	NULL
of	NULL
an	NULL
interleukin	NULL
4	NULL
(	NULL
IL-4	NULL
)	NULL
responsive	NULL
region	NULL
in	NULL
the	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
germline	NULL
e	NULL
promoter	NULL
:	NULL
regulation	NULL
by	NULL
NF-IL-4	NULL
,	NULL
a	NULL
C/EBP	NULL
family	NULL
member	NULL
and	NULL
NF-	NULL
«	NULL
B/p50	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181	NULL
:	NULL
181	NULL
.	NULL

Berton	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Linehan	NULL
.	NULL

1995	NULL
.	NULL

IL-4	NULL
activates	NULL
a	NULL
latent	NULL
DNA-binding	NULL
factor	NULL
that	NULL
binds	NULL
a	NULL
shared	NULL
IFN-y	NULL
and	NULL
IL-4	NULL
response	NULL
element	NULL
present	NULL
in	NULL
the	NULL
germline	NULL
yl	NULL
Ig	NULL
promoter	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154:4513	NULL
.	NULL

Lin	NULL
,	NULL
S.-C.	NULL
,	NULL
and	NULL
J.	NULL
Stavnezer	NULL
.	NULL

1996	NULL
.	NULL

Activation	NULL
of	NULL
NF-	NULL
«	NULL
kB/Rel	NULL
by	NULL
CD40	NULL
engagement	NULL
induces	NULL
the	NULL
mouse	NULL
germ	NULL
line	NULL
immunoglobulin	NULL
Cy1	NULL
promoter	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:4591	NULL
.	NULL

Iciek	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
S.	NULL
A.	NULL
Delphin	NULL
,	NULL
and	NULL
J.	NULL
Stavnezer	NULL
.	NULL

1997	NULL
.	NULL

CD40	NULL
cross-linking	NULL
induces	NULL
Ige	NULL
germline	NULL
transcripts	NULL
in	NULL
B	NULL
cells	NULL
via	NULL
activation	NULL
of	NULL
NF-x	NULL
B	NULL
:	NULL
synergy	NULL
with	NULL
IL-4	NULL
induction	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158:4769	NULL
.	NULL

Shimoda	NULL
,	NULL
K.	NULL
,	NULL
J.	NULL
van	NULL
Deursen	NULL
,	NULL
M.	NULL
Y.	NULL
Sangster	NULL
,	NULL
S.	NULL
R	NULL
Sarawar	NULL
,	NULL
R.	NULL
T.	NULL
Carson	NULL
,	NULL
R.	NULL
A.	NULL
Tripp	NULL
,	NULL
C.	NULL
Chu	NULL
,	NULL
F.	NULL
W.	NULL
Quelle	NULL
,	NULL
T.	NULL
Nosaka	NULL
,	NULL
D.	NULL
A.	NULL
Vignali	NULL
,	NULL
P.	NULL
C.	NULL
Doherty	NULL
,	NULL
G.	NULL
Grosveld	NULL
,	NULL
W.	NULL
E.	NULL
Paul	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Thle	NULL
.	NULL

1996	NULL
.	NULL

Lack	NULL
of	NULL
IL-4-induced	NULL
Th2	NULL
response	NULL
and	NULL
IgE	NULL
class	NULL
switching	NULL
in	NULL
mice	NULL
with	NULL
disrupted	NULL
Stat6	NULL
gene	NULL
.	NULL

Nature	NULL
380:630	NULL
.	NULL

Zelazowski	NULL
,	NULL
P.	NULL
,	NULL
D.	NULL
Carrasco	NULL
,	NULL
F.	NULL
R.	NULL
Rosas	NULL
,	NULL
M.	NULL
A.	NULL
Moorman	NULL
,	NULL
R.	NULL
Bravo	NULL
,	NULL
and	NULL
C.	NULL
M.	NULL
Snapper	NULL
.	NULL

1997	NULL
.	NULL

B	NULL
cell	NULL
genetically	NULL
deficient	NULL
in	NULL
the	NULL
c-Rel	NULL
transactivation	NULL
domain	NULL
have	NULL
selective	NULL
defects	NULL
in	NULL
germline	NULL
C	NULL
;	NULL
,	NULL
transcription	NULL
and	NULL
Ig	NULL
class	NULL
switching	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:3133	NULL
.	NULL

Snapper	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
P.	NULL
Zelazowski	NULL
,	NULL
F.	NULL
R.	NULL
Rosas	NULL
,	NULL
M.	NULL
R.	NULL
Kehry	NULL
,	NULL
M.	NULL
Tian	NULL
,	NULL
D.	NULL
Baltimore	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Sha	NULL
.	NULL

1996	NULL
.	NULL

B	NULL
cells	NULL
from	NULL
pSO/NF-	NULL
«	NULL
B	NULL
knockout	NULL
mice	NULL
have	NULL
selective	NULL
defects	NULL
in	NULL
proliferation	NULL
,	NULL
differentiation	NULL
,	NULL
germ-line	NULL
C	NULL
;	NULL
,	NULL
transcription	NULL
,	NULL
and	NULL
Ig	NULL
class	NULL
switching	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

156:183	NULL
.	NULL

Linchan	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
W.	NULL
D.	NULL
Warren	NULL
,	NULL
P.	NULL
A.	NULL
Thompson	NULL
,	NULL
M.	NULL
J.	NULL
Grusby	NULL
,	NULL
and	NULL
M.	NULL
T.	NULL
Berton	NULL
.	NULL

1998	NULL
.	NULL

STAT6	NULL
is	NULL
required	NULL
for	NULL
IL-4-induced	NULL
germline	NULL
Ig	NULL
gene	NULL
transcription	NULL
and	NULL
switch	NULL
recombination	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:302	NULL
.	NULL

Ichiki	NULL
,	NULL
T.	NULL
,	NULL
W.	NULL
Takahashi	NULL
,	NULL
and	NULL
T.	NULL
Watanabe	NULL
.	NULL

1993	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
human	NULL
Ce	NULL
germline	NULL
transcript	NULL
:	NULL
identification	NULL
of	NULL
a	NULL
novel	NULL
IL-4	NULL
responsive	NULL
element	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

150:5408	NULL
.	NULL

Albrecht	NULL
,	NULL
B.	NULL
,	NULL
S.	NULL
Peiritsch	NULL
,	NULL
and	NULL
M.	NULL
Woisetschlager	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
bifunctional	NULL
control	NULL
element	NULL
in	NULL
the	NULL
human	NULL
IgE	NULL
germline	NULL
promoter	NULL
involved	NULL
in	NULL
repression	NULL
and	NULL
IL-4	NULL
activation	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

6:1143	NULL
.	NULL

Fujita	NULL
,	NULL
K.	NULL
,	NULL
M.	NULL
D.	NULL
Jumper	NULL
,	NULL
K.	NULL
Meck	NULL
,	NULL
and	NULL
P.	NULL
E.	NULL
Lipsky	NULL
.	NULL

1995	NULL
.	NULL

Evidence	NULL
for	NULL
a	NULL
CD40	NULL
response	NULL
element	NULL
,	NULL
distinct	NULL
from	NULL
the	NULL
IL-4	NULL
response	NULL
element	NULL
,	NULL
in	NULL
the	NULL
germline	NULL
e	NULL
promoter	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

7:1529	NULL
.	NULL

Thienes	NULL
,	NULL
C.	NULL
P.	NULL
,	NULL
L.	NULL
De	NULL
Monte	NULL
,	NULL
S.	NULL
Monticelli	NULL
,	NULL
M.	NULL
Busslinger	NULL
,	NULL
H.	NULL
J.	NULL
Gould	NULL
,	NULL
and	NULL
D.	NULL
Vercelli	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
B	NULL
cell-specific	NULL
activator	NULL
protein	NULL
(	NULL
BSAP	NULL
)	NULL
enhances	NULL
both	NULL
IL-4-	NULL
and	NULL
CD4O-mediated	NULL
activation	NULL
of	NULL
the	NULL
human	NULL
e	NULL
germline	NULL
promoter	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158:5874	NULL
.	NULL

Messner	NULL
,	NULL
B.	NULL
,	NULL
A.	NULL
M.	NULL
Stiitz	NULL
,	NULL
B.	NULL
Albrecht	NULL
,	NULL
S.	NULL
Peiritsch	NULL
,	NULL
and	NULL
M.	NULL
Woisetschliiger	NULL
.	NULL

1997	NULL
.	NULL

Cooperation	NULL
of	NULL
binding	NULL
sites	NULL
for	NULL
STAT6	NULL
and	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

in	NULL
the	NULL
IL-4-induced	NULL
up-regulation	NULL
of	NULL
the	NULL
human	NULL
IgE	NULL
germline	NULL
promoter	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:3330	NULL
.	NULL

Lars	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
S.	NULL
Paschalis	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
human	NULL
Ial	NULL
and	NULL
germline	NULL
promoter	NULL
elements	NULL
:	NULL
proximal	NULL
positive	NULL
and	NULL
distal	NULL
negative	NULL
elements	NULL
may	NULL
regulate	NULL
the	NULL
tissue	NULL
specific	NULL
expression	NULL
of	NULL
Cal	NULL
and	NULL
Ca2	NULL
germline	NULL
transcripts	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

5:271	NULL
.	NULL

Nilsson	NULL
,	NULL
L.	NULL
,	NULL
P.	NULL
Grant	NULL
,	NULL
I.	NULL
Larsson	NULL
,	NULL
S.	NULL
Pettersson	NULL
,	NULL
and	NULL
P.	NULL
Sideras	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
human	NULL
Tal	NULL
region	NULL
contains	NULL
a	NULL
responsive	NULL
enhancer	NULL
and	NULL
a	NULL
putative	NULL
recombination	NULL
hotspot	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

7:1191	NULL
.	NULL

Kuze	NULL
,	NULL
K.	NULL
,	NULL
A.	NULL
Shimizu	NULL
,	NULL
and	NULL
T.	NULL
Honjo	NULL
.	NULL

1991	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
enhancer	NULL
region	NULL
for	NULL
germline	NULL
transcription	NULL
of	NULL
the	NULL
y3	NULL
constant	NULL
region	NULL
gene	NULL
of	NULL
human	NULL
im-munoglobulin	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

3:647	NULL
.	NULL

Zan	NULL
,	NULL
H.	NULL
,	NULL
A.	NULL
Cerutti	NULL
,	NULL
P.	NULL
Dramitinos	NULL
,	NULL
A.	NULL
Schaffer	NULL
,	NULL
Z.	NULL
Li	NULL
,	NULL
and	NULL
P.	NULL
Casali	NULL
.	NULL

1999	NULL
.	NULL

Induction	NULL
of	NULL
Ig	NULL
somatic	NULL
hypermutation	NULL
and	NULL
class	NULL
switching	NULL
in	NULL
a	NULL
human	NULL
monoclonal	NULL
IgM	NULL
*	NULL
IgD*	NULL
B	NULL
cell	NULL
line	NULL
in	NULL
vitro	NULL
:	NULL
definition	NULL
of	NULL
the	NULL
requirements	NULL
and	NULL
modalities	NULL
of	NULL
hypermutation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

162:3437	NULL
.	NULL

Liao	NULL
,	NULL
F.	NULL
,	NULL
B.	NULL
K.	NULL
Birshtcin	NULL
,	NULL
M.	NULL
Busslinger	NULL
,	NULL
and	NULL
P.	NULL
Rothman	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
BSAP	NULL
(	NULL
NF-HB	NULL
)	NULL
is	NULL
essential	NULL
for	NULL
immunoglobulin	NULL
germ-line	NULL
e	NULL
transcription	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

152:2904	NULL
.	NULL

Lundgren	NULL
,	NULL
M.	NULL
,	NULL
C.	NULL
Larsson	NULL
,	NULL
A.	NULL
Femino	NULL
,	NULL
M.	NULL
Xu	NULL
,	NULL
J.	NULL
Stavnezer	NULL
,	NULL
and	NULL
E.	NULL
Severinson	NULL
.	NULL

1994	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
Ig	NULL
germ-line	NULL
y1	NULL
promoter	NULL
:	NULL
involvement	NULL
of	NULL
C/enhancer-binding	NULL
protein	NULL
transcription	NULL
factors	NULL
and	NULL
their	NULL
possible	NULL
interaction	NULL
with	NULL
an	NULL
NF-IL-4	NULL
site	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:2983	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
5336	NULL
36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

Kotanides	NULL
,	NULL
H.	NULL
,	NULL
M.	NULL
Moczygemba	NULL
,	NULL
M.	NULL
F.	NULL
White	NULL
,	NULL
and	NULL
N.	NULL
C.	NULL
Reich	NULL
.	NULL

1995	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
interleukin-4	NULL
nuclear	NULL
activated	NULL
factor/STAT	NULL
and	NULL
its	NULL
activation	NULL
independent	NULL
of	NULL
the	NULL
insulin	NULL
receptor	NULL
substrate	NULL
proteins	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:19481	NULL
.	NULL

Jumper	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Splawski	NULL
,	NULL
P.	NULL
E.	NULL
Lipsky	NULL
,	NULL
and	NULL
K.	NULL
Meck	NULL
.	NULL

1994	NULL
.	NULL

Ligation	NULL
of	NULL
CD40	NULL
induces	NULL
sterile	NULL
transcripts	NULL
of	NULL
multiple	NULL
Ig	NULL
H	NULL
chain	NULL
isotypes	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

152:438	NULL
.	NULL

Fujieda	NULL
,	NULL
S.	NULL
,	NULL
K.	NULL
Zhang	NULL
,	NULL
and	NULL
A.	NULL
Saxon	NULL
.	NULL

1995	NULL
.	NULL

IL-4	NULL
plus	NULL
CD40	NULL
monoclonal	NULL
antibody	NULL
induces	NULL
human	NULL
B	NULL
cells	NULL
-y	NULL
subclass-specific	NULL
isotype	NULL
switch	NULL
:	NULL
switching	NULL
to	NULL
y1	NULL
,	NULL
43	NULL
,	NULL
and	NULL
74	NULL
,	NULL
but	NULL
not	NULL
42	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

155:2318	NULL
.	NULL

Snapper	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
F.	NULL
R.	NULL
Rosas	NULL
,	NULL
P.	NULL
Zelazowski	NULL
,	NULL
M.	NULL
A.	NULL
Moorman	NULL
,	NULL
M.	NULL
R.	NULL
Kehry	NULL
,	NULL
R.	NULL
Bravo	NULL
,	NULL
and	NULL
F.	NULL
Weih	NULL
.	NULL

1996	NULL
.	NULL

B	NULL
cells	NULL
lacking	NULL
RelB	NULL
are	NULL
defective	NULL
in	NULL
proliferative	NULL
responses	NULL
,	NULL
but	NULL
undergo	NULL
normal	NULL
B	NULL
cell	NULL
maturation	NULL
to	NULL
Ig	NULL
secretion	NULL
and	NULL
Ig	NULL
class	NULL
switching	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184:1537	NULL
.	NULL

Mikita	NULL
,	NULL
T.	NULL
,	NULL
D.	NULL
Campbell	NULL
,	NULL
P.	NULL
Wu	NULL
,	NULL
K.	NULL
Williamson	NULL
,	NULL
and	NULL
U.	NULL
Schindler	NULL
.	NULL

1996	NULL
.	NULL

Requirements	NULL
for	NULL
interleukin-4-induced	NULL
gene	NULL
expression	NULL
and	NULL
functional	NULL
characterization	NULL
of	NULL
Stat6	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:5811	NULL
.	NULL

LeClair	NULL
,	NULL
K.	NULL
P.	NULL
,	NULL
M.	NULL
A.	NULL
Blanar	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
pSQ	NULL
subunit	NULL
of	NULL
NF-KB	NULL
associates	NULL
with	NULL
the	NULL
NF-IL6	NULL
transcription	NULL
factor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
;	NULL
8145	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
P.	NULL
C.	NULL
Cogswell	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1993	NULL
.	NULL

Functional	NULL
and	NULL
physical	NULL
associations	NULL
between	NULL
NF-kB	NULL
and	NULL
C/EBP	NULL
family	NULL
members	NULL
:	NULL
a	NULL
Rel	NULL
domain-bZIP	NULL
interaction	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:3964	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

HUMAN	NULL
ECS-Iy3	NULL
IS	NULL
A	NULL
FUNCTIONAL	NULL
GENE	NULL
PROMOTER	NULL
Stein	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1993	NULL
.	NULL

Distinct	NULL
mechanisms	NULL
for	NULL
regulation	NULL
of	NULL
the	NULL
interleukin-8	NULL
gene	NULL
involve	NULL
synergism	NULL
and	NULL
cooperativity	NULL
between	NULL
C/EBP	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:7191	NULL
.	NULL

Kaszubska	NULL
,	NULL
W.	NULL
R.	NULL
,	NULL
R.	NULL
H.	NULL
van	NULL
Huijsduijnen	NULL
,	NULL
P.	NULL
Ghersa	NULL
,	NULL
A.-M.	NULL
deRaemy-Schenk	NULL
,	NULL
B.	NULL
P.	NULL
C.	NULL
Chen	NULL
,	NULL
T.	NULL
Hai	NULL
,	NULL
J.	NULL
F.	NULL
de	NULL
Lamarter	NULL
,	NULL
and	NULL
J.	NULL
Whelan	NULL
.	NULL

1993	NULL
.	NULL

Cyclic	NULL
AMP-independent	NULL
ATF	NULL
family	NULL
members	NULL
interact	NULL
with	NULL
NF-KB	NULL
and	NULL
function	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
E-selectin	NULL
promoter	NULL
in	NULL
response	NULL
to	NULL
cytokines	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:7180	NULL
.	NULL

Whitley	NULL
,	NULL
M.	NULL
Z.	NULL
,	NULL
D.	NULL
Thanos	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

Read	NULL
,	NULL
T.	NULL
Maniatis	NULL
,	NULL
and	NULL
T.	NULL
Collins	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
striking	NULL
similarity	NULL
in	NULL
the	NULL
organization	NULL
of	NULL
the	NULL
E-selectin	NULL
and	NULL
B-interferon	NULL
gene	NULL
promoters	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

14:6464	NULL
.	NULL

Rothe	NULL
,	NULL
M.	NULL
,	NULL
V.	NULL
Sarma	NULL
,	NULL
V.	NULL
M.	NULL
Dixit	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Goeddel	NULL
.	NULL

1995	NULL
.	NULL

TRAF2-mediated	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
TNF	NULL
receptor	NULL
2	NULL
and	NULL
CD40	NULL
.	NULL

Science	NULL
269:1424	NULL
.	NULL

Kuhne	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
M.	NULL
Robbins	NULL
,	NULL
J.	NULL
E.	NULL
Hambor	NULL
,	NULL
M.	NULL
F.	NULL
Mackey	NULL
,	NULL
Y.	NULL
Kosaka	NULL
,	NULL
T.	NULL
Nishimura	NULL
,	NULL
J.	NULL
P.	NULL
Gigley	NULL
,	NULL
R.	NULL
J.	NULL
Noelle	NULL
,	NULL
and	NULL
M.	NULL
Calderhead	NULL
.	NULL

1998	NULL
.	NULL

Assembly	NULL
and	NULL
regulation	NULL
of	NULL
the	NULL
CD40	NULL
receptor	NULL
complex	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

186:337	NULL
.	NULL

Cheshire	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
S.	NULL
Baldwin	NULL
.	NULL

1997	NULL
.	NULL

Synergistic	NULL
activation	NULL
of	NULL
NF-kB	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
and	NULL
y	NULL
interferon	NULL
via	NULL
enhanced	NULL
IxBa	NULL
degradation	NULL
and	NULL
de	NULL
novo	NULL
IBB	NULL
degradation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:6746	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL

